<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><?properties manuscript?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-journal-id">9203213</journal-id><journal-id journal-id-type="pubmed-jr-id">1135</journal-id><journal-id journal-id-type="nlm-ta">Clin Infect Dis</journal-id><journal-id journal-id-type="iso-abbrev">Clin Infect Dis</journal-id><journal-title-group><journal-title>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</journal-title></journal-title-group><issn pub-type="ppub">1058-4838</issn><issn pub-type="epub">1537-6591</issn></journal-meta><article-meta><article-id pub-id-type="pmid">24065331</article-id><article-id pub-id-type="pmc">11005812</article-id><article-id pub-id-type="doi">10.1093/cid/cit642</article-id><article-id pub-id-type="manuscript">HHSPA1981998</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Causes of Death and Characteristics of Decedents With Viral Hepatitis, United States, 2010</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ly</surname><given-names>Kathleen N.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Xing</surname><given-names>Jian</given-names></name></contrib><contrib contrib-type="author"><name><surname>Klevens</surname><given-names>R. Monina</given-names></name></contrib><contrib contrib-type="author"><name><surname>Jiles</surname><given-names>Ruth B.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Holmberg</surname><given-names>Scott D.</given-names></name></contrib><aff id="A1">Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, Georgia</aff></contrib-group><author-notes><fn fn-type="con" id="FN1"><p id="P1"><bold><italic toggle="yes">Author contributions</italic></bold>. Study concept and design: K. N. L., J. X., R. M. K., R. B. J., and S. D. H.; acquisition of data: K. N. L. and J. X.; analysis and interpretation of data: K. N. L., J. X., R. M. K., R. B. J., and S. D. H.; drafting of the manuscript: K. N. L., R. M. K., R. B. J., and S. D. H.; critical revision of the manuscript for important intellectual content: K. N. L., R. M. K., R. B. J., and S. D. H.; statistical expertise: J. X.; obtained funding: R. B. J. and S. D. H.; administrative, technical, or material support: R. B. J. and S. D. H.; study supervision: R. B. J., R. M. K., and S. D. H.</p></fn><corresp id="CR1">Correspondence: Kathleen N. Ly, MPH, Division of Viral Hepatitis, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Mailstop G-37, Atlanta, GA 30333 (<email>kathleenly@cdc.gov</email>).</corresp></author-notes><pub-date pub-type="nihms-submitted"><day>30</day><month>3</month><year>2024</year></pub-date><pub-date pub-type="ppub"><month>1</month><year>2014</year></pub-date><pub-date pub-type="epub"><day>24</day><month>9</month><year>2013</year></pub-date><pub-date pub-type="pmc-release"><day>10</day><month>4</month><year>2024</year></pub-date><volume>58</volume><issue>1</issue><fpage>40</fpage><lpage>49</lpage><permissions><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This work is written by (a) US Government employee(s) and is in the public domain in the US.</license-p></license></permissions><abstract id="ABS1"><sec id="S1"><title>Background.</title><p id="P2">Previous research indicates that the mortality burden from viral hepatitis is growing, particularly among middle-aged persons. To monitor progress toward prevention goals, it is important to continue to document characteristics and comortalities of these deaths. This study sought to examine demographic characteristics and the most frequent causes of death among decedents with a viral hepatitis&#x02013;related death.</p></sec><sec id="S2"><title>Methods.</title><p id="P3">A cross-sectional study was performed on approximately 2.4 million death records from 2010. We calculated mortality rates for decedents with and without hepatitis A, B, and C virus (HAV, HBV, and HCV) and relative risks for the most frequently cited conditions in decedents with and without HBV and HCV.</p></sec><sec id="S3"><title>Results.</title><p id="P4">In 2010, there were 18 473 (0.7%) deaths with HAV, HBV, and HCV listed among causes of death, disproportionately in those aged 45&#x02013;64 years. Among the 10 frequent causes of death, decedents listing HBV or HCV died, on average, 22&#x02013;23 years earlier than decedents not listing these infections. HBV- and HCV-infected decedents aged 45&#x02013;64 years had an increased risk of having the following conditions reported than decedents without these infections: cancer of liver and intrahepatic bile duct; fibrosis, cirrhosis, and other liver diseases; alcohol-related liver disease; gastrointestinal hemorrhage; human immunodeficiency infection; acute and unspecified renal failure; and septicemia (HCV only).</p></sec><sec id="S4"><title>Conclusions.</title><p id="P5">Decedents with other causes of death that include HBV or HCV died 22&#x02013;23 years earlier than decedents not listing these infections. These data suggest and support the need for prevention, early identification, and treatment of HBV and HCV.</p></sec></abstract><kwd-group><kwd>viral hepatitis</kwd><kwd>mortality</kwd><kwd>death certificates</kwd><kwd>causes of death</kwd></kwd-group></article-meta></front><body><p id="P6">In the United States, hepatitis A virus (HAV), hepatitis B virus (HBV), and hepatitis C virus (HCV) are nationally notifiable infectious conditions and are routinely reported and monitored through national surveillance [<xref rid="R1" ref-type="bibr">1</xref>]. Hepatitis A and acute hepatitis B and C are reportable by law in all states and the District of Columbia; chronic hepatitis B and C are reportable by law in 43 states and the District of Columbia. Reporting of these conditions is based upon standard case definitions established in collaboration with the Centers for Disease Control and Prevention (CDC) and the Council of State and Territorial Epidemiologists [<xref rid="R2" ref-type="bibr">2</xref>].</p><p id="P7">While the incidence of hepatitis A, B, and C is at an all-time low [<xref rid="R1" ref-type="bibr">1</xref>]<bold><italic toggle="yes">&#x02014;</italic></bold>creating the misconception that further prevention efforts are unnecessary<bold><italic toggle="yes">&#x02014;</italic></bold>foodborne outbreaks for hepatitis A and healthcare-associated outbreaks for hepatitis B and C continue to occur each year [<xref rid="R1" ref-type="bibr">1</xref>]. For hepatitis A, mortality occurs most frequently among persons aged &#x02265;45 years [<xref rid="R1" ref-type="bibr">1</xref>] and persons with underlying chronic liver disease [<xref rid="R3" ref-type="bibr">3</xref>]. For hepatitis B and C, mortality occurs most frequently among persons aged 45&#x02013;64 years [<xref rid="R4" ref-type="bibr">4</xref>], and chronic infection accounts for the majority of the total burden. One reason why mortality occurs disproportionately in this relatively younger age group is because up to 65% [<xref rid="R5" ref-type="bibr">5</xref>] of the estimated 730 000 [<xref rid="R6" ref-type="bibr">6</xref>] US residents with hepatitis B and up to 75% [<xref rid="R5" ref-type="bibr">5</xref>] of the estimated 3.2 million [<xref rid="R7" ref-type="bibr">7</xref>] US residents with hepatitis C are asymptomatic; many are unaware of their infection [<xref rid="R8" ref-type="bibr">8</xref>]. Still, these prevalence estimates, which were obtained from the National Health and Nutrition Examination Survey, are considered conservative because high-risk groups, specifically homeless and institutionalized persons, were not included. Although important for estimating and describing the total burden of disease and for tracking and targeting prevention activities, an analysis describing hepatitis A, B, and C mortality rates by detailed demographic characteristics has not been performed for the United States.</p><p id="P8">Additionally, while hepatitis B and C are well-recognized causes of liver-related disease [<xref rid="R9" ref-type="bibr">9</xref>], understanding the effect of these viruses on other frequently occurring comorbidities that lead to death is becoming appreciated [<xref rid="R10" ref-type="bibr">10</xref>&#x02013;<xref rid="R13" ref-type="bibr">13</xref>]. Specifically, studies have concluded that HCV infection significantly increased the risk of dying from all causes and nonliver-related causes [<xref rid="R10" ref-type="bibr">10</xref>, <xref rid="R11" ref-type="bibr">11</xref>]. Additionally, all-cause mortality among HCV-infected patients in 4 US healthcare networks was nearly 3 times higher than all-cause mortality among HCV-uninfected persons in the noninstitutionalized US population [<xref rid="R13" ref-type="bibr">13</xref>]. However, similar studies for hepatitis B have not been performed in a representative US population. Additionally, to our knowledge, this is the first study to document the most common or frequent causes of death among decedents with hepatitis B and C.</p><p id="P9">Our goal was to use US multiple-cause-of-death (MCOD) data, mainly for hepatitis B and C, from 2010 to (1) characterize the national burden of mortality associated with and without hepatitis A, B, and C by describing incidence rates for select detailed demographic characteristics; (2) compare the most frequently listed causes of death among persons with and without a death associated with hepatitis B and C; and (3) calculate the risk of dying with the most frequently cited conditions among persons aged 45&#x02013;64 years with a death associated with hepatitis B and C.</p><sec id="S5"><title>METHODS</title><sec id="S6"><title>MCOD Data</title><p id="P10">This study used the public-use 2010 US MCOD data file, which contains information on all registered deaths occurring within the calendar year [<xref rid="R14" ref-type="bibr">14</xref>]. State vital registration offices house these death certificates and, through a cooperative agreement, compile and share this information with the National Center for Health Statistics (NCHS). NCHS then uses this information to generate the annual national multiple-cause mortality datasets.</p><p id="P11">The conditions on the cause of death section of the death certificate are reported by the decedent&#x02019;s physician, hospital residents, medical examiner, or coroner. The types of causes of death are the underlying, immediate, intermediate, and contributing causes of death that, together, are called the multiple causes of death. In MCOD files, these conditions are translated into <italic toggle="yes">International Classification of Diseases, Tenth Revision</italic> (<italic toggle="yes">ICD-10</italic>) [<xref rid="R15" ref-type="bibr">15</xref>], codes by highly skilled nosologists at NCHS using 2 schemes: entity axis and record axis. The entity axis represents a direct transcription of each disease entity listed on the cause of death section of the death certificate. The record axis represents a modified version of the entity axis in which repetitive conditions and inconsistencies are removed, related conditions are joined, and coding rules are followed [<xref rid="R16" ref-type="bibr">16</xref>]. An example of how conditions are coded is as follows: a death certificate with cirrhosis of liver and alcoholism as causes of death would be directly transcribed to <italic toggle="yes">ICD-10</italic> codes K74 (cirrhosis of liver without mention of alcohol) and F10 (alcohol dependence syndrome) as entity axis conditions. These conditions represent separate entities for the same death record. Searching for death records with <italic toggle="yes">ICD-10</italic> code K74 would, on the surface, seem that such records had no mention of alcohol. Therefore, a preferable record axis code would be K70.3 (alcoholic cirrhosis of liver), which would encompass both <italic toggle="yes">ICD-10</italic> codes K74 and F10.</p></sec><sec id="S7"><title>Definitions</title><p id="P12">For the purpose of this study, hepatitis A-, B-, and C-related deaths were defined using 2 definitions. First, deaths citing HAV (<italic toggle="yes">ICD-10</italic>: B15), HBV (<italic toggle="yes">ICD-10</italic>: B16, B17.0, B18.0, and B18.1), or HCV (<italic toggle="yes">ICD-10</italic>: B17.1 and B18.2) as the underlying cause or associated cause of death in the record axis was counted. Second, any death with HIV (<italic toggle="yes">ICD-10</italic>: B20&#x02013;B24) as the underlying cause and HAV, HBV, or HCV as an associated cause of death in either the record or entity axis was counted. The second definition was implemented to ensure that deaths where coinfection with HIV and viral hepatitis occurred were not excluded due to the frequent reassignment of HIV as the underlying cause of death and the tendency for viral hepatitis to be excluded when translation from entity to record axis occurs [<xref rid="R4" ref-type="bibr">4</xref>, <xref rid="R18" ref-type="bibr">18</xref>, <xref rid="R19" ref-type="bibr">19</xref>]. For hepatitis B and C, the decision to combine acute and chronic <italic toggle="yes">ICD-10</italic> codes was based on a study that found that chronic hepatitis B and C deaths were often incorrectly coded as acute [<xref rid="R20" ref-type="bibr">20</xref>]. The term &#x0201c;viral hepatitis&#x0201d; refers to hepatitis A, B, and C, collectively. The terms &#x0201c;with hepatitis&#x0201d; and &#x0201c;without hepatitis&#x0201d; are used for decedents who had and did not have hepatitis listed as a cause of death, respectively.</p></sec><sec id="S8"><title>Statistical Analyses</title><p id="P13">Demographic information on age, race/ethnicity, and sex were examined, and mortality rates were calculated from this information. For this analysis (<xref rid="T1" ref-type="table">Table 1</xref>), deaths listing more than 1 hepatitis infection were assigned a single infection based on a mutually exclusive hierarchy: hepatitis A &#x0003e; hepatitis B &#x0003e; hepatitis C. The hierarchy was based on the need to fully describe characteristics of deaths with hepatitis A and B as hepatitis C carried the highest mortality burden and the degree of co-hepatitis infection was small. Age was divided into the following categories: 0&#x02013;34, 35&#x02013;44, 45&#x02013;54, 65&#x02013;74, and &#x02265;75 years. Race/ethnicity was classified as Asian/Pacific Islander, American Indian/Alaska native, non-Hispanic (NH) white, NH black, and Hispanic. Mortality rates were calculated using the 2010 US bridged-race approximations [<xref rid="R21" ref-type="bibr">21</xref>] and were standardized to the age distribution of the 2000 US standard population [<xref rid="R22" ref-type="bibr">22</xref>]. The Poisson distribution was used to estimate the variance for rates and to calculate 95% confidence intervals (CIs) [<xref rid="R23" ref-type="bibr">23</xref>].</p><p id="P14">To determine the most frequently reported causes of death (<xref rid="T2" ref-type="table">Tables 2</xref> and <xref rid="T3" ref-type="table">3</xref>), <italic toggle="yes">ICD-10</italic> codes among deaths with and without hepatitis B and C were isolated from the record axis and classified according to the Clinical Classifications Software (CCS) for <italic toggle="yes">ICD-10</italic>; this is a well-developed categorization scheme that collapsed approximately 32 000 <italic toggle="yes">ICD-10</italic> codes into 260 clinically meaningful and manageable categories [<xref rid="R24" ref-type="bibr">24</xref>]. For the CCS category labeled &#x0201c;Other Liver Diseases&#x0201d; in decedents with hepatitis B or hepatitis C, liver fibrosis and cirrhosis (<italic toggle="yes">ICD-10</italic>, K74) was the most frequently listed; therefore, we renamed this category with the more descriptive label of &#x0201c;Fibrosis, Cirrhosis, and Other Liver Diseases.&#x0201d; Liver-associated conditions included the following CCS categories: fibrosis, cirrhosis, and other liver diseases; other hepatitis infections; cancer of the liver and intrahepatic bile duct; alcohol-related liver disease; and gastrointestinal hemorrhage. The median age at death for each of the top 10 CCS categories was examined. Then, the difference was determined by calculating the average of the median ages for the 10 most frequently cited causes among decedents with and without hepatitis B and C and subtracting these 2 averages.</p><p id="P15">Relative risks were calculated to quantify the risk of dying with the 15 most frequently cited conditions among decedents aged 45&#x02013;64 years who had hepatitis B and C listed among causes of death. The comparison group was decedents belonging to the same age group who did not have hepatitis B and C listed. For this analysis, we included deaths with either hepatitis B alone or hepatitis C alone (but not those who were coinfected) to remove the effect of potential confounders on the results of deaths with hepatitis B, which accounted for 30% of hepatitis B deaths. We separately compared the relative risks of all deaths with hepatitis B together (hepatitis B alone plus hepatitis B/C coinfected) with hepatitis B alone and found that the magnitude of association of liver-associated and HIV-associated conditions with hepatitis B would be more similar to those of hepatitis C had hepatitis B/C coinfected deaths been included, therefore justifying the removal of the coinfected.</p><p id="P16">The 95% CIs were used to determine the variance and statistical significance of each relative risk estimate. Data were analyzed using SAS software, version 9.2 (SAS Institute, Cary, NC).</p></sec></sec><sec id="S9"><title>RESULTS</title><p id="P17">In 2010, 2 472 542 deaths were registered in the United States, of which 18 473 (0.7%) listed hepatitis A, B, or C among causes of death. This implied an age-adjusted mortality rate of 5.2 deaths per 100 000 population (<xref rid="T1" ref-type="table">Table 1</xref>). Hepatitis A was listed as the underlying cause of 30 deaths (&#x0003c;0.01%) and as any cause of 96 deaths (&#x0003c;0.01%; <xref rid="F1" ref-type="fig">Figure 1</xref>). Hepatitis B was listed as the underlying cause of 589 deaths (0.02%) and as any cause of 1875 deaths (0.08%). Hepatitis C was listed as the underlying cause of 6857 deaths (0.28%) and as any cause of 17 113 deaths (0.69%). Among deaths with hepatitis A, B, or C, 92.6% were with hepatitis C, 10.1% were with hepatitis B, and 0.5% was with hepatitis A. Among deaths with hepatitis C, 3.4% had hepatitis A and/or B. Among deaths with hepatitis B, 1.7% had hepatitis A.</p><p id="P18">Among decedents with hepatitis A, the highest mortality rates were observed among persons aged &#x02265;45 years and accounted for 89.6% of hepatitis A&#x02013;related deaths (<xref rid="T1" ref-type="table">Table 1</xref>). Among decedents with hepatitis B, the highest mortality rates were observed among persons aged 55&#x02013;64 years, Asians/Pacific Islanders, and males. Among decedents with hepatitis C, the highest mortality rates were observed among persons aged 55&#x02013;64 years; the American Indian/Alaskan Native, NH black, and Hispanic race/ethnic groups; and males. In comparison, among decedents without viral hepatitis, the highest mortality rates were observed among persons aged &#x02265;75 years, NH blacks, and males.</p><p id="P19">The most frequently listed category among deaths with either hepatitis B or hepatitis C was fibrosis, cirrhosis, and other liver diseases (45.3% and 48.4%, respectively; <xref rid="T2" ref-type="table">Tables 2</xref> and <xref rid="T3" ref-type="table">3</xref>). Cancer of the liver, including hepatocellular carcinoma, and intrahepatic bile duct and alcohol-related liver disease were also frequently reported in deaths with hepatitis B and C (11.6%&#x02013;22.8%). The most frequently reported nonliver-associated conditions among decedents with either hepatitis B or C were cardiac arrest and ventricular fibrillation, substance-related mental disorders, diabetes mellitus without complication, essential hypertension, and adult respiratory failure insufficiency arrest (8.9%&#x02013;14.0%). Septicemia (except in labor) was among the top 10 most frequently reported conditions for hepatitis C but not for hepatitis B.</p><p id="P20">For deaths without hepatitis B or C, liver-associated conditions were not among the top 10 categories. Further, the top causes occurred at a lower frequency for any 1 category (7.2%&#x02013;15.1%) than the top causes among deaths with hepatitis B or C (8.9%&#x02013;48.4%; <xref rid="T2" ref-type="table">Tables 2</xref> and <xref rid="T3" ref-type="table">3</xref>). Among the 10 most frequently cited causes, deaths listing hepatitis B and C occurred at an average median age of 22&#x02013;23 years younger than deaths not listing hepatitis B and C.</p><p id="P21">Among decedents aged 45&#x02013;64 years, the relative risks for conditions associated with a significantly increased risk of dying with hepatitis B ranged from 14.0 (cancer of liver and intrahepatic bile duct) to 2.6 (acute and unspecified renal failure; <xref rid="T4" ref-type="table">Table 4</xref>). Coronary atherosclerosis and other heart disease and substance-related mental disorders (relative risk, 0.5 and 0.7, respectively) were the 2 conditions associated with a significantly decreased risk of dying with hepatitis B.</p><p id="P22">Among the same age group, the relative risks for conditions associated with a significantly increased risk of dying with hepatitis C ranged from 12.0 (cancer of liver and intrahepatic bile duct) to 1.5 (septicemia, except in labor; <xref rid="T5" ref-type="table">Table 5</xref>). The relative risks for conditions associated with a significantly decreased risk of dying with hepatitis C ranged from 0.6 (all external causes of injury and poisoning) to 0.9 (respiratory failure, insufficiency, arrest<bold><italic toggle="yes">&#x02014;</italic></bold>adult).</p></sec><sec id="S10"><title>DISCUSSION</title><p id="P23">Our analysis of 2010 MCOD data identified 18 473 deaths reported with viral hepatitis. If ranked as a leading cause of death using NCHS&#x02019;s list [<xref rid="R25" ref-type="bibr">25</xref>], viral hepatitis would rank as the 15th leading cause of death.</p><p id="P24">Hepatitis C alone was identified as a cause of nearly 90% of these deaths; the majority of those occurred in persons aged 45&#x02013;64 years. The disproportionate burden in this age group is consistent with other studies [<xref rid="R4" ref-type="bibr">4</xref>, <xref rid="R7" ref-type="bibr">7</xref>, <xref rid="R18" ref-type="bibr">18</xref>]. As a result, in 2012, the CDC recommended 1-time hepatitis C testing for persons born during 1945&#x02013;1965 (aged 45&#x02013;65 years in 2010) [<xref rid="R26" ref-type="bibr">26</xref>], especially because birth-cohort screening in primary care settings is cost effective [<xref rid="R27" ref-type="bibr">27</xref>]. Our study provides evidence that strengthens this national recommendation. Moreover, the well-demonstrated increased mortality of both liver-associated and nonliver-associated conditions in HBV- and HCV-infected decedents provides key evidence to get more people treated before they develop serious illness.</p><p id="P25">In our comparative cause-of-death analysis, hepatitis B- or C-related deaths most frequently also had liver-associated conditions, which supports the established literature on outcomes of chronic hepatitis infection. Our most significant finding, however, was that among decedents with the same cause of death, persons with hepatitis B or C died about 2 decades younger than persons without these infections. Prevention and early treatment of hepatitis B and C will help prevent these early deaths. Evidence suggests that early therapeutic intervention improves all-cause hepatitis B and C mortality [<xref rid="R28" ref-type="bibr">28</xref>&#x02013;<xref rid="R30" ref-type="bibr">30</xref>].</p><p id="P26">Illicit drug use is associated with an increased likelihood of HBV and HCV infection [<xref rid="R7" ref-type="bibr">7</xref>]. In this study, while we showed that substance-related mental disorders were reported frequently among causes of death in persons aged 45&#x02013;64 years, regardless if HBV and HCV infections were present, the relative risk of dying with a substance-related mental disorder, however, was less likely in deaths with hepatitis B and was not significant in deaths with hepatitis C. For hepatitis B, the decreased likelihood of dying may be explained by the fact that the majority of HBV-infected decedents in the 45&#x02013;64 year age group were Asians/Pacific Islanders, who most likely acquired their infection during birth or early childhood. For hepatitis C, the insignificant relative risk of dying may be explained by the fact that most persons aged 45&#x02013;64 years may have used illicit drugs infrequently during their youth, and the behavior is more common among adolescents and young adults. To support this assumption, we did find a significant elevated risk of dying with substance-related mental disorders in HCV-infected decedents aged 0&#x02013;44 years (data not shown).</p><p id="P27">Our study demonstrated racial/ethnic disparities in deaths with hepatitis C, specifically among American Indians/Alaskan Natives, NH blacks, and Hispanics. While health disparities in minorities with chronic HCV infection have been documented since as early as 1999 [<xref rid="R4" ref-type="bibr">4</xref>, <xref rid="R31" ref-type="bibr">31</xref>, <xref rid="R32" ref-type="bibr">32</xref>], we and others [<xref rid="R4" ref-type="bibr">4</xref>] showed that this trend, unfortunately, has not improved.</p><p id="P28">Although we could not obtain vaccination status from death certificates, our data showed that 3.4% of decedents with hepatitis C had hepatitis A and/or hepatitis B and 1.7% of decedents with hepatitis B had hepatitis A, indicating vaccination was probably not received. Even though hepatitis A and B vaccination is recommended for HCV-infected patients [<xref rid="R33" ref-type="bibr">33</xref>], this recommendation had the lowest quality-of-care indicator score in an evaluation study of HCV-infected patients<bold><italic toggle="yes">&#x02014;</italic></bold>only 22% received hepatitis A vaccination and only 26% received hepatitis B vaccination or had documented immunity [<xref rid="R34" ref-type="bibr">34</xref>].</p><p id="P29">Although the results of this study are population based, the findings should be interpreted with caution. First, the inaccuracy of cause-of-death coding on death certificates is a significant problem that can lead to underestimates in the viral hepatitis mortality burden [<xref rid="R35" ref-type="bibr">35</xref>, <xref rid="R36" ref-type="bibr">36</xref>]; therefore, the hepatitis death estimates in this analysis likely represent only a small fraction of the true burden. Despite having guidelines and training in place, a study at Johns Hopkins Medical Institutions found that more than 40% of causes of death were improperly filled out [<xref rid="R36" ref-type="bibr">36</xref>]. In addition to the variability in completeness of recording viral hepatitis deaths, there are data from studies that used medical records to validate hepatitis B and/or C as causes of death in healthcare networks (Mahajan et al, unpublished data) [<xref rid="R37" ref-type="bibr">37</xref>]. Investigators found that for patients who had a known HBV [<xref rid="R37" ref-type="bibr">37</xref>] or HCV [<xref rid="R37" ref-type="bibr">37</xref>, 38] infection associated with chronic liver disease at death, this information was often not reported on death certificates, even when end stage liver disease or hepatocellular carcinoma were listed as the main cause of death. The viral hepatitis mortality burden is even further underestimated by undiagnosed hepatitis infections and deaths unrelated to the decedent&#x02019;s hepatitis infection, such as those that resulted from a suicide or vehicle accident. Because death certificate data imperfectly collect cause of death information, this analysis can only provide data for which viral hepatitis is or is not mentioned on the death certificate. Despite these limitations, MCOD data are invaluable in that they capture all registered deaths in the United States, providing an insightful view into the national burden of viral hepatitis mortality.</p><p id="P30">In summary, viral hepatitis was listed as a cause of more than 18 000 recorded US deaths in 2010, and there are many who are likely not diagnosed or recorded as having these hepatitides [<xref rid="R37" ref-type="bibr">37</xref>]. Because these data demonstrated that death occurred 22&#x02013;23 years earlier among persons with an HBV- or HCV-related death, prevention efforts should be expanded to further (1) promote hepatitis A and B vaccination among recommended target groups, (2) increase hepatitis B and C screening to get more people into care and earlier treatment, and (3) treat alcohol- and drug-related disorders [<xref rid="R26" ref-type="bibr">26</xref>].</p></sec></body><back><ack id="S11"><title>Acknowledgments.</title><p id="P31">The authors thank Robert Hobbs, Michael Bank-head, and India Hayes for their support in creating the Venn diagram.</p><sec id="S12"><title>Financial support.</title><p id="P32">Kathleen Ly was supported in part by an appointment to the Research Participation Program at the CDC administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the US Department of Energy and the CDC.</p></sec></ack><fn-group><fn id="FN2"><p id="P33"><bold><italic toggle="yes">Disclaimer</italic></bold>. The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention (CDC).</p></fn><fn fn-type="COI-statement" id="FN3"><p id="P34"><bold><italic toggle="yes">Potential conflicts of interest</italic></bold>. The authors disclose no conflicts relevant to this study. All authors: No reported conflicts.</p><p id="P35">All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed</p></fn></fn-group><ref-list><title>References</title><ref id="R1"><label>1.</label><mixed-citation publication-type="webpage"><collab>Centers for Disease Control and Prevention</collab>. <source>Viral hepatitis surveillance&#x02014;United States, 2009</source>. <year>2011</year>. <comment>Available at: <ext-link xlink:href="http://www.cdc.gov/hepatitis/Statistics/2009Surveillance/index.htm" ext-link-type="uri">http://www.cdc.gov/hepatitis/Statistics/2009Surveillance/index.htm</ext-link>.</comment>
<comment>Accessed</comment>
<date-in-citation>20 December 2011</date-in-citation>.</mixed-citation></ref><ref id="R2"><label>2.</label><mixed-citation publication-type="webpage"><collab>Centers for Disease Control and Prevention</collab>. <source>CDC/CSTE Case Definitions</source>. <comment>Available at: <ext-link xlink:href="http://wwwn.cdc.gov/NNDSS/script/casedefDefault.aspx" ext-link-type="uri">http://wwwn.cdc.gov/NNDSS/script/casedefDefault.aspx</ext-link>.</comment>
<comment>Accessed</comment>
<date-in-citation>5 September 2013</date-in-citation>.</mixed-citation></ref><ref id="R3"><label>3.</label><mixed-citation publication-type="journal"><name><surname>Vogt</surname><given-names>T</given-names></name>, <name><surname>Wise</surname><given-names>M</given-names></name>, <name><surname>Bell</surname><given-names>B</given-names></name>, <name><surname>Finelli</surname><given-names>L</given-names></name>. <article-title>Declining hepatitis A mortality in the United States during the era of hepatitis A vaccination</article-title>. <source>J Infect Dis</source>
<year>2008</year>; <volume>197</volume>:<fpage>1282</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">18422440</pub-id>
</mixed-citation></ref><ref id="R4"><label>4.</label><mixed-citation publication-type="journal"><name><surname>Ly</surname><given-names>K</given-names></name>, <name><surname>Xing</surname><given-names>J</given-names></name>, <name><surname>Klevens</surname><given-names>R</given-names></name>, <name><surname>Jiles</surname><given-names>R</given-names></name>, <name><surname>Ward</surname><given-names>J</given-names></name>, <name><surname>Holmberg</surname><given-names>S</given-names></name>. <article-title>The growing burden of mortality from viral hepatitis in the United States, 1999&#x02013;2007</article-title>. <source>Ann Intern Med</source>
<year>2012</year>; <volume>156</volume>:<fpage>271</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">22351712</pub-id>
</mixed-citation></ref><ref id="R5"><label>5.</label><mixed-citation publication-type="book"><collab>Institute of Medicine</collab>. <name><surname>Colvin</surname><given-names>HM</given-names></name>, <name><surname>Mitchell</surname><given-names>AE</given-names></name>, eds. <source>Hepatitis and liver cancer: a national strategy for prevention and control of hepatitis B and C</source>. <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>The National Academies Press</publisher-name>, <year>2010</year>.</mixed-citation></ref><ref id="R6"><label>6.</label><mixed-citation publication-type="journal"><name><surname>Wasley</surname><given-names>A</given-names></name>, <name><surname>Kruszon-Moran</surname><given-names>D</given-names></name>, <name><surname>Kuhnert</surname><given-names>W</given-names></name>, <etal/>
<article-title>The prevalence of hepatitis B virus infection in the United States in the era of vaccination</article-title>. <source>J Infect Dis</source>
<year>2010</year>; <volume>202</volume>:<fpage>192</fpage>&#x02013;<lpage>201</lpage>.<pub-id pub-id-type="pmid">20533878</pub-id>
</mixed-citation></ref><ref id="R7"><label>7.</label><mixed-citation publication-type="journal"><name><surname>Armstrong</surname><given-names>G</given-names></name>, <name><surname>Wasley</surname><given-names>A</given-names></name>, <name><surname>Simard</surname><given-names>E</given-names></name>, <name><surname>McQuillan</surname><given-names>G</given-names></name>, <name><surname>Kuhnert</surname><given-names>W</given-names></name>, <name><surname>Alter</surname><given-names>M</given-names></name>. <article-title>The prevalence of hepatitis C virus infection in the United States, 1999 through 2002</article-title>. <source>Ann Intern Med</source>
<year>2006</year>; <volume>144</volume>:<fpage>705</fpage>&#x02013;<lpage>14</lpage>.<pub-id pub-id-type="pmid">16702586</pub-id>
</mixed-citation></ref><ref id="R8"><label>8.</label><mixed-citation publication-type="journal"><name><surname>Volk</surname><given-names>M</given-names></name>, <name><surname>Tocco</surname><given-names>R</given-names></name>, <name><surname>Saini</surname><given-names>S</given-names></name>, <name><surname>Lok</surname><given-names>A</given-names></name>. <article-title>Public health impact of antiviral therapy for hepatitis C in the United States</article-title>. <source>Hepatology</source>
<year>2009</year>; <volume>50</volume>:<fpage>1750</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="pmid">19824079</pub-id>
</mixed-citation></ref><ref id="R9"><label>9.</label><mixed-citation publication-type="journal"><name><surname>Bell</surname><given-names>B</given-names></name>, <name><surname>Manos</surname><given-names>M</given-names></name>, <name><surname>Zaman</surname><given-names>A</given-names></name>, <name><surname>Terrault</surname><given-names>N</given-names></name>, <name><surname>Thomas</surname><given-names>A</given-names></name>. <article-title>The epidemiology of newly diagnosed chronic liver disease in gastroenterology practices in the United States: results from population-based surveillance</article-title>. <source>Am J Gastroenterol</source>
<year>2008</year>; <volume>103</volume>:<fpage>2727</fpage>&#x02013;<lpage>36</lpage>.<pub-id pub-id-type="pmid">18684170</pub-id>
</mixed-citation></ref><ref id="R10"><label>10.</label><mixed-citation publication-type="journal"><name><surname>Lee</surname><given-names>M</given-names></name>, <name><surname>Yang</surname><given-names>H</given-names></name>, <name><surname>Lu</surname><given-names>S</given-names></name>, <etal/>
<article-title>Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study</article-title>. <source>J Infect Dis</source>
<year>2012</year>; <volume>206</volume>:<fpage>469</fpage>&#x02013;<lpage>77</lpage>.<pub-id pub-id-type="pmid">22811301</pub-id>
</mixed-citation></ref><ref id="R11"><label>11.</label><mixed-citation publication-type="journal"><name><surname>El-Kamary</surname><given-names>S</given-names></name>, <name><surname>Jhaveri</surname><given-names>R</given-names></name>, <name><surname>Shardell</surname><given-names>M</given-names></name>. <article-title>All-cause, liver-related, and non&#x02013;liver-related mortality among HCV-infected individuals in the general U.S. population</article-title>. <source>Clin Infect Dis</source>
<year>2011</year>; <volume>53</volume>:<fpage>150</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">21665867</pub-id>
</mixed-citation></ref><ref id="R12"><label>12.</label><mixed-citation publication-type="journal"><name><surname>Amin</surname><given-names>J</given-names></name>, <name><surname>Law</surname><given-names>MG</given-names></name>, <name><surname>Bartlett</surname><given-names>M</given-names></name>, <name><surname>Kaldor</surname><given-names>JM</given-names></name>, <name><surname>Dore</surname><given-names>GJ</given-names></name>. <article-title>Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study</article-title>. <source>Lancet</source>
<year>2006</year>; <volume>368</volume>:<fpage>938</fpage>&#x02013;<lpage>45</lpage>.<pub-id pub-id-type="pmid">16962883</pub-id>
</mixed-citation></ref><ref id="R13"><label>13.</label><mixed-citation publication-type="journal"><name><surname>Moorman</surname><given-names>A</given-names></name>, <name><surname>Gordon</surname><given-names>S</given-names></name>, <name><surname>Rupp</surname><given-names>L</given-names></name>, <etal/>
<article-title>Baseline characteristics and mortality among people in care for chronic viral hepatitis: the Chronic Hepatitis Cohort Study</article-title>. <source>Clin Infect Dis</source>
<year>2013</year>; <volume>56</volume>:<fpage>40</fpage>&#x02013;<lpage>50</lpage>.<pub-id pub-id-type="pmid">22990852</pub-id>
</mixed-citation></ref><ref id="R14"><label>14.</label><mixed-citation publication-type="webpage"><collab>National Center for Health Statistics</collab>. <source>Mortality multiple cause-of-death public use record for 2010, as compiled from data provided by the 57 vital statistics jurisdictions through the Vital Statistics Cooperative Program</source>. <comment>Available at: <ext-link xlink:href="http://www.cdc.gov/nchs/nvss/mortality_methods.htm" ext-link-type="uri">http://www.cdc.gov/nchs/nvss/mortality_methods.htm</ext-link>.</comment>
<comment>Accessed</comment>
<date-in-citation>27 May 2013</date-in-citation>.</mixed-citation></ref><ref id="R15"><label>15.</label><mixed-citation publication-type="book"><collab>World Health Organization</collab>. <part-title>International Classification of Diseases</part-title>. <source>10th Revision</source>. <publisher-loc>Geneva, Switzerland</publisher-loc>: <publisher-name>WHO</publisher-name>, <year>1998</year>. <comment>Available at: <ext-link xlink:href="http://apps.who.int/classifications/icd10/browse/2010/en" ext-link-type="uri">http://apps.who.int/classifications/icd10/browse/2010/en</ext-link>.</comment>
<comment>Accessed</comment>
<date-in-citation>14 June 2013</date-in-citation>.</mixed-citation></ref><ref id="R16"><label>16.</label><mixed-citation publication-type="webpage"><collab>National Center for Health Statistics</collab>. <source>Public use data set documentation&#x02014;mortality for ICD-10</source>. <year>1999</year>. <comment>Available at: <ext-link xlink:href="http://ftp.cdc.gov/pub/health_statistics/nchs/Dataset_Documentation/mortality/Mort99doc.pdf" ext-link-type="uri">http://ftp.cdc.gov/pub/health_statistics/nchs/Dataset_Documentation/mortality/Mort99doc.pdf</ext-link>.</comment>
<comment>Accessed</comment>
<date-in-citation>15 June 2010</date-in-citation>.</mixed-citation></ref><ref id="R17"><label>17.</label><mixed-citation publication-type="webpage"><collab>Institute for Social Research, University of Michigan</collab>. <source>Coded causes of death</source>. <comment>Available at: <ext-link xlink:href="http://simba.isr.umich.edu/restricted/docs/Mortality/codedcauses_readfirst.pdf" ext-link-type="uri">http://simba.isr.umich.edu/restricted/docs/Mortality/codedcauses_readfirst.pdf</ext-link>.</comment>
<comment>Accessed</comment>
<date-in-citation>5 September 2013</date-in-citation>.</mixed-citation></ref><ref id="R18"><label>18.</label><mixed-citation publication-type="journal"><name><surname>Wise</surname><given-names>M</given-names></name>, <name><surname>Bialek</surname><given-names>S</given-names></name>, <name><surname>Finelli</surname><given-names>L</given-names></name>, <name><surname>Beth</surname><given-names>B</given-names></name>, <name><surname>Sorvillo</surname><given-names>F</given-names></name>. <article-title>Changing trends in hepatitis C-related mortality in the United States, 1995&#x02013;2004</article-title>. <source>Hepatology</source>
<year>2008</year>; <volume>47</volume>:<fpage>1128</fpage>&#x02013;<lpage>35</lpage>.<pub-id pub-id-type="pmid">18318441</pub-id>
</mixed-citation></ref><ref id="R19"><label>19.</label><mixed-citation publication-type="webpage"><collab>National Center for Health Statistics</collab>. <source>Instructions for classifying the underlying cause of death, ICD-10, 2010</source>. <comment>Available at: <ext-link xlink:href="http://www.cdc.gov/nchs/data/dvs/2A_2010acc.pdf" ext-link-type="uri">http://www.cdc.gov/nchs/data/dvs/2A_2010acc.pdf</ext-link>.</comment>
<comment>Accessed</comment>
<date-in-citation>4 April 2011</date-in-citation>.</mixed-citation></ref><ref id="R20"><label>20.</label><mixed-citation publication-type="journal"><name><surname>Thomas</surname><given-names>A</given-names></name>, <name><surname>Zaman</surname><given-names>A</given-names></name>, <name><surname>Bell</surname><given-names>B</given-names></name>. <article-title>Deaths from chronic liver disease and viral hepatitis, Multnomah County, Oregon, 2000</article-title>. <source>J Clin Gastroenterol</source>
<year>2007</year>; <volume>41</volume>:<fpage>859</fpage>&#x02013;<lpage>62</lpage>.<pub-id pub-id-type="pmid">17881933</pub-id>
</mixed-citation></ref><ref id="R21"><label>21.</label><mixed-citation publication-type="webpage"><collab>National Center for Health Statistics</collab>. <source>Vintage 2010 bridged-race post-censal population estimates</source>. <comment>Available at: <ext-link xlink:href="http://www.cdc.gov/nchs/nvss/bridged_race/data_documentation.htm#vintage2010" ext-link-type="uri">http://www.cdc.gov/nchs/nvss/bridged_race/data_documentation.htm#vintage2010</ext-link>.</comment>
<comment>Accessed</comment>
<date-in-citation>13 October 2012</date-in-citation>.</mixed-citation></ref><ref id="R22"><label>22.</label><mixed-citation publication-type="journal"><name><surname>Klein</surname><given-names>R</given-names></name>, <name><surname>Schoenborn</surname><given-names>C</given-names></name>. <article-title>Age adjustment using the 2000 projected U.S. population. Healthy People 2010</article-title>. <source>Stat Notes</source>
<year>2001</year>; <volume>20</volume>:<fpage>1</fpage>&#x02013;<lpage>10</lpage>.</mixed-citation></ref><ref id="R23"><label>23.</label><mixed-citation publication-type="journal"><name><surname>Mini&#x000f1;o</surname><given-names>A</given-names></name>, <name><surname>Murphy</surname><given-names>S</given-names></name>, <name><surname>Xu</surname><given-names>J</given-names></name>, <name><surname>Kochanek</surname><given-names>K</given-names></name>. <article-title>Deaths: final data for 2008</article-title>. <source>Natl Vital Stat Rep</source>
<year>2011</year>; <volume>59</volume>:<fpage>1</fpage>&#x02013;<lpage>157</lpage>.</mixed-citation></ref><ref id="R24"><label>24.</label><mixed-citation publication-type="webpage"><collab>Agency for Healthcare Research and Quality</collab>. <source>Clinical classifications software (CCS) for ICD-10</source>. <comment>Available at: <ext-link xlink:href="http://www.hcup-us.ahrq.gov/toolssoftware/icd_10/ccs_icd_10.jsp" ext-link-type="uri">http://www.hcup-us.ahrq.gov/toolssoftware/icd_10/ccs_icd_10.jsp</ext-link>.</comment>
<comment>Accessed</comment>
<date-in-citation>15 March 2011</date-in-citation>.</mixed-citation></ref><ref id="R25"><label>25.</label><mixed-citation publication-type="journal"><name><surname>Murphy</surname><given-names>S</given-names></name>, <name><surname>Xu</surname><given-names>J</given-names></name>, <name><surname>Kochanek</surname><given-names>K</given-names></name>. <article-title>Deaths: preliminary data for 2010</article-title>. <source>Natl Vital Stat Rep</source>
<year>2012</year>; <volume>60</volume>:<fpage>1</fpage>&#x02013;<lpage>68</lpage>.</mixed-citation></ref><ref id="R26"><label>26.</label><mixed-citation publication-type="journal"><collab>Centers for Disease Control and Prevention</collab>. <article-title>Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945&#x02013;1965</article-title>. <source>MMWR Recomm Rep</source>
<year>2012</year>; <volume>61</volume>(<issue>RR04</issue>): <fpage>1</fpage>&#x02013;<lpage>18</lpage>.</mixed-citation></ref><ref id="R27"><label>27.</label><mixed-citation publication-type="journal"><name><surname>Rein</surname><given-names>D</given-names></name>, <name><surname>Smith</surname><given-names>B</given-names></name>, <name><surname>Wittenborn</surname><given-names>J</given-names></name>, <etal/>
<article-title>The cost-effectiveness of birth-cohort screening for hepatitis C antibody in U.S. primary care settings</article-title>. <source>Ann Intern Med</source>
<year>2012</year>; <volume>156</volume>:<fpage>263</fpage>&#x02013;<lpage>70</lpage>.<pub-id pub-id-type="pmid">22056542</pub-id>
</mixed-citation></ref><ref id="R28"><label>28.</label><mixed-citation publication-type="journal"><name><surname>Backus</surname><given-names>L</given-names></name>, <name><surname>Boothroyd</surname><given-names>D</given-names></name>, <name><surname>Phillips</surname><given-names>B</given-names></name>, <name><surname>Belperio</surname><given-names>P</given-names></name>, <name><surname>Halloran</surname><given-names>J</given-names></name>, <name><surname>Mole</surname><given-names>L</given-names></name>. <article-title>A sustained virologic response reduces risk of all-cause mortality in patients with hepatitis C</article-title>. <source>Clin Gastroenterol Hepatol</source>
<year>2011</year>; <volume>9</volume>:<fpage>509</fpage>&#x02013;<lpage>16</lpage>.<pub-id pub-id-type="pmid">21397729</pub-id>
</mixed-citation></ref><ref id="R29"><label>29.</label><mixed-citation publication-type="journal"><name><surname>van der Meer</surname><given-names>A</given-names></name>, <name><surname>Veldt</surname><given-names>B</given-names></name>, <name><surname>Feld</surname><given-names>J</given-names></name>, <etal/>
<article-title>Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis</article-title>. <source>JAMA</source>
<year>2012</year>; <volume>308</volume>:<fpage>2584</fpage>&#x02013;<lpage>93</lpage>.<pub-id pub-id-type="pmid">23268517</pub-id>
</mixed-citation></ref><ref id="R30"><label>30.</label><mixed-citation publication-type="journal"><name><surname>Schiff</surname><given-names>E</given-names></name>
<article-title>Prevention of mortality from hepatitis B and hepatitis C</article-title>. <source>Lancet</source>
<year>2006</year>; <volume>368</volume>:<fpage>896</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">16962862</pub-id>
</mixed-citation></ref><ref id="R31"><label>31.</label><mixed-citation publication-type="journal"><name><surname>El-Serag</surname><given-names>H</given-names></name>, <name><surname>Mason</surname><given-names>A</given-names></name>. <article-title>Rising incidence of hepatocellular carcinoma in the United States</article-title>. <source>N Engl J Med</source>
<year>1999</year>; <volume>340</volume>:<fpage>745</fpage>&#x02013;<lpage>50</lpage>.<pub-id pub-id-type="pmid">10072408</pub-id>
</mixed-citation></ref><ref id="R32"><label>32.</label><mixed-citation publication-type="journal"><name><surname>El-Serag</surname><given-names>H</given-names></name>
<article-title>Hepatocellular carcinoma: recent trends in the United States</article-title>. <source>Gastroenterology</source>
<year>2004</year>; <volume>127</volume>:<fpage>s27</fpage>&#x02013;<lpage>34</lpage>.<pub-id pub-id-type="pmid">15508094</pub-id>
</mixed-citation></ref><ref id="R33"><label>33.</label><mixed-citation publication-type="webpage"><collab>Centers for Medicare &#x00026; Medicaid Services</collab>. <source>Overview: Physician Quality Reporting Initiative</source>. <comment>Available at: <ext-link xlink:href="http://www.cms.hhs.gov/pqri/" ext-link-type="uri">www.cms.hhs.gov/pqri/</ext-link>.</comment>
<comment>Accessed</comment>
<date-in-citation>14 June 2010</date-in-citation>.</mixed-citation></ref><ref id="R34"><label>34.</label><mixed-citation publication-type="journal"><name><surname>Kanwal</surname><given-names>F</given-names></name>, <name><surname>Schnitzler</surname><given-names>M</given-names></name>, <name><surname>Bacon</surname><given-names>B</given-names></name>, <name><surname>Hoang</surname><given-names>T</given-names></name>, <name><surname>Buchanan</surname><given-names>P</given-names></name>, <name><surname>Asch</surname><given-names>S</given-names></name>. <article-title>Quality of care in patients with chronic hepatitis C virus infection</article-title>. <source>Ann Intern Med</source>
<year>2010</year>; <volume>153</volume>:<fpage>231</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">20713791</pub-id>
</mixed-citation></ref><ref id="R35"><label>35.</label><mixed-citation publication-type="journal"><name><surname>Wexelman</surname><given-names>BA</given-names></name>, <name><surname>Eden</surname><given-names>E</given-names></name>, <name><surname>Rose</surname><given-names>KM</given-names></name>. <article-title>Survey of New York City resident physicians on cause-of-death reporting, 2010</article-title>. <source>Prev Chronic Dis</source>
<year>2013</year>; <volume>10</volume>:<fpage>1</fpage>&#x02013;<lpage>12</lpage>.</mixed-citation></ref><ref id="R36"><label>36.</label><mixed-citation publication-type="journal"><name><surname>Sehdev</surname><given-names>A</given-names></name>, <name><surname>Hutchins</surname><given-names>G</given-names></name>. <article-title>Problems with proper completion and accuracy of the cause-of-death statement</article-title>. <source>Arch Intern Med</source>
<year>2001</year>; <volume>161</volume>: <fpage>277</fpage>&#x02013;<lpage>84</lpage>.<pub-id pub-id-type="pmid">11176744</pub-id>
</mixed-citation></ref><ref id="R37"><label>37.</label><mixed-citation publication-type="journal"><name><surname>Manos</surname><given-names>M</given-names></name>, <name><surname>Leyden</surname><given-names>W</given-names></name>, <name><surname>Murphy</surname><given-names>R</given-names></name>, <name><surname>Terrault</surname><given-names>N</given-names></name>, <name><surname>Bell</surname><given-names>B</given-names></name>. <article-title>Limitations of conventionally derived chronic liver disease mortality rates: results of a comprehensive assessment</article-title>. <source>Hepatology</source>
<year>2008</year>; <volume>47</volume>:<fpage>1150</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">18264998</pub-id>
</mixed-citation></ref></ref-list></back><floats-group><fig position="float" id="F1"><label>Figure 1.</label><caption><p id="P36">Number of deaths reported with hepatitis A, B, and C in the United States, 2010, N = 18 473.</p></caption><graphic xlink:href="nihms-1981998-f0001" position="float"/></fig><table-wrap position="float" id="T1" orientation="landscape"><label>Table 1.</label><caption><p id="P37">Age-Adjusted and Age-Specific Mortality Rates With and Without Hepatitis A, B, and C by Demographic Characteristics in the United States, 2010</p></caption><table frame="above" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th rowspan="2" align="left" valign="bottom" colspan="1">Characteristic</th><th colspan="3" align="center" valign="bottom" style="border-bottom: solid 1px" rowspan="1">Hepatitis A, B, or C</th><th colspan="3" align="center" valign="bottom" style="border-bottom: solid 1px" rowspan="1">Hepatitis A</th><th colspan="3" align="center" valign="bottom" style="border-bottom: solid 1px" rowspan="1">Hepatitis B</th><th colspan="3" align="center" valign="bottom" style="border-bottom: solid 1px" rowspan="1">Hepatitis C</th><th colspan="3" align="center" valign="bottom" style="border-bottom: solid 1px" rowspan="1">Non-Hepatitis A, B, or C</th></tr><tr><th align="center" valign="bottom" rowspan="1" colspan="1">Number</th><th align="center" valign="bottom" rowspan="1" colspan="1">Rate</th><th align="center" valign="bottom" rowspan="1" colspan="1">(95% CI)</th><th align="center" valign="bottom" rowspan="1" colspan="1">Number</th><th align="center" valign="bottom" rowspan="1" colspan="1">Rate</th><th align="center" valign="bottom" rowspan="1" colspan="1">(95% CI)</th><th align="center" valign="bottom" rowspan="1" colspan="1">Number</th><th align="center" valign="bottom" rowspan="1" colspan="1">Rate</th><th align="center" valign="bottom" rowspan="1" colspan="1">(95% CI)</th><th align="center" valign="bottom" rowspan="1" colspan="1">Number</th><th align="center" valign="bottom" rowspan="1" colspan="1">Rate</th><th align="center" valign="bottom" rowspan="1" colspan="1">(95% CI)</th><th align="center" valign="bottom" rowspan="1" colspan="1">Number</th><th align="center" valign="bottom" rowspan="1" colspan="1">Rate</th><th align="center" valign="bottom" rowspan="1" colspan="1">(95% CI)</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Overall</td><td align="right" valign="top" rowspan="1" colspan="1">18 473</td><td align="center" valign="top" rowspan="1" colspan="1">5.19</td><td align="center" valign="top" rowspan="1" colspan="1">(5.11&#x02013;5.28)</td><td align="right" valign="top" rowspan="1" colspan="1">96</td><td align="left" valign="top" rowspan="1" colspan="1">0.03</td><td align="center" valign="top" rowspan="1" colspan="1">(.02&#x02013;.03)</td><td align="right" valign="top" rowspan="1" colspan="1">1844</td><td align="center" valign="top" rowspan="1" colspan="1">0.54</td><td align="center" valign="top" rowspan="1" colspan="1">(.51&#x02013;.57)</td><td align="right" valign="top" rowspan="1" colspan="1">16 533</td><td align="center" valign="top" rowspan="1" colspan="1">4.62</td><td align="center" valign="top" rowspan="1" colspan="1">(4.54&#x02013;4.71)</td><td align="right" valign="top" rowspan="1" colspan="1">2 454 069</td><td align="center" valign="top" rowspan="1" colspan="1">764.76</td><td align="center" valign="top" rowspan="1" colspan="1">(763.72&#x02013;765.79)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Age group, y<sup><xref rid="TFN3" ref-type="table-fn">a</xref></sup></td><td align="right" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="right" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="right" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="right" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="right" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;&#x02264;34</td><td align="right" valign="top" rowspan="1" colspan="1">172</td><td align="center" valign="top" rowspan="1" colspan="1">0.12</td><td align="center" valign="top" rowspan="1" colspan="1">(.10&#x02013;.14)</td><td align="right" valign="top" rowspan="1" colspan="1">3</td><td align="left" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">(.00&#x02013;.01)</td><td align="right" valign="top" rowspan="1" colspan="1">50</td><td align="center" valign="top" rowspan="1" colspan="1">0.03</td><td align="center" valign="top" rowspan="1" colspan="1">(.03&#x02013;.05)</td><td align="right" valign="top" rowspan="1" colspan="1">119</td><td align="center" valign="top" rowspan="1" colspan="1">0.08</td><td align="center" valign="top" rowspan="1" colspan="1">(.07&#x02013;.10)</td><td align="right" valign="top" rowspan="1" colspan="1">106 344</td><td align="center" valign="top" rowspan="1" colspan="1">72.88</td><td align="center" valign="top" rowspan="1" colspan="1">(72.44&#x02013;73.32)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;35&#x02013;44</td><td align="right" valign="top" rowspan="1" colspan="1">894</td><td align="center" valign="top" rowspan="1" colspan="1">2.18</td><td align="center" valign="top" rowspan="1" colspan="1">(2.04&#x02013;2.32)</td><td align="right" valign="top" rowspan="1" colspan="1">7</td><td align="left" valign="top" rowspan="1" colspan="1">0.02</td><td align="center" valign="top" rowspan="1" colspan="1">(.01&#x02013;.04)</td><td align="right" valign="top" rowspan="1" colspan="1">157</td><td align="center" valign="top" rowspan="1" colspan="1">0.38</td><td align="center" valign="top" rowspan="1" colspan="1">(.33&#x02013;.45)</td><td align="right" valign="top" rowspan="1" colspan="1">730</td><td align="center" valign="top" rowspan="1" colspan="1">1.78</td><td align="center" valign="top" rowspan="1" colspan="1">(1.65&#x02013;1.91)</td><td align="right" valign="top" rowspan="1" colspan="1">69 421</td><td align="center" valign="top" rowspan="1" colspan="1">169.03</td><td align="center" valign="top" rowspan="1" colspan="1">(167.78&#x02013;170.29)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;45&#x02013;54</td><td align="right" valign="top" rowspan="1" colspan="1">5690</td><td align="center" valign="top" rowspan="1" colspan="1">12.64</td><td align="center" valign="top" rowspan="1" colspan="1">(12.32&#x02013;12.98)</td><td align="right" valign="top" rowspan="1" colspan="1">25</td><td align="left" valign="top" rowspan="1" colspan="1">0.06</td><td align="center" valign="top" rowspan="1" colspan="1">(.04&#x02013;.08)</td><td align="right" valign="top" rowspan="1" colspan="1">475</td><td align="center" valign="top" rowspan="1" colspan="1">1.06</td><td align="center" valign="top" rowspan="1" colspan="1">(.96&#x02013;1.15)</td><td align="right" valign="top" rowspan="1" colspan="1">5190</td><td align="center" valign="top" rowspan="1" colspan="1">11.53</td><td align="center" valign="top" rowspan="1" colspan="1">(11.22&#x02013;11.85)</td><td align="right" valign="top" rowspan="1" colspan="1">178 093</td><td align="center" valign="top" rowspan="1" colspan="1">395.70</td><td align="center" valign="top" rowspan="1" colspan="1">(393.87&#x02013;397.55)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;55&#x02013;64</td><td align="right" valign="top" rowspan="1" colspan="1">7996</td><td align="center" valign="top" rowspan="1" colspan="1">21.92</td><td align="center" valign="top" rowspan="1" colspan="1">(21.44&#x02013;22.40)</td><td align="right" valign="top" rowspan="1" colspan="1">35</td><td align="left" valign="top" rowspan="1" colspan="1">0.1</td><td align="center" valign="top" rowspan="1" colspan="1">(.07&#x02013;.13)</td><td align="right" valign="top" rowspan="1" colspan="1">618</td><td align="center" valign="top" rowspan="1" colspan="1">1.69</td><td align="center" valign="top" rowspan="1" colspan="1">(1.57&#x02013;1.83)</td><td align="right" valign="top" rowspan="1" colspan="1">7343</td><td align="center" valign="top" rowspan="1" colspan="1">20.13</td><td align="center" valign="top" rowspan="1" colspan="1">(19.67&#x02013;20.59)</td><td align="right" valign="top" rowspan="1" colspan="1">303 545</td><td align="center" valign="top" rowspan="1" colspan="1">832.02</td><td align="center" valign="top" rowspan="1" colspan="1">(829.07&#x02013;834.99)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;65&#x02013;74</td><td align="right" valign="top" rowspan="1" colspan="1">2180</td><td align="center" valign="top" rowspan="1" colspan="1">10.04</td><td align="center" valign="top" rowspan="1" colspan="1">(9.63&#x02013;10.47)</td><td align="right" valign="top" rowspan="1" colspan="1">10</td><td align="left" valign="top" rowspan="1" colspan="1">0.05</td><td align="center" valign="top" rowspan="1" colspan="1">(.02&#x02013;.09)</td><td align="right" valign="top" rowspan="1" colspan="1">297</td><td align="center" valign="top" rowspan="1" colspan="1">1.37</td><td align="center" valign="top" rowspan="1" colspan="1">(1.22&#x02013;1.53)</td><td align="right" valign="top" rowspan="1" colspan="1">1873</td><td align="center" valign="top" rowspan="1" colspan="1">8.63</td><td align="center" valign="top" rowspan="1" colspan="1">(8.24&#x02013;9.03)</td><td align="right" valign="top" rowspan="1" colspan="1">405 790</td><td align="center" valign="top" rowspan="1" colspan="1">1868.84</td><td align="center" valign="top" rowspan="1" colspan="1">(1863.10&#x02013;1874.60)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;&#x02265;75</td><td align="right" valign="top" rowspan="1" colspan="1">1539</td><td align="center" valign="top" rowspan="1" colspan="1">8.29</td><td align="center" valign="top" rowspan="1" colspan="1">(7.89&#x02013;8.72)</td><td align="right" valign="top" rowspan="1" colspan="1">16</td><td align="left" valign="top" rowspan="1" colspan="1">0.09</td><td align="center" valign="top" rowspan="1" colspan="1">(.05&#x02013;.14)</td><td align="right" valign="top" rowspan="1" colspan="1">247</td><td align="center" valign="top" rowspan="1" colspan="1">1.33</td><td align="center" valign="top" rowspan="1" colspan="1">(1.18&#x02013;1.51)</td><td align="right" valign="top" rowspan="1" colspan="1">1276</td><td align="center" valign="top" rowspan="1" colspan="1">6.88</td><td align="center" valign="top" rowspan="1" colspan="1">(6.51&#x02013;7.26)</td><td align="right" valign="top" rowspan="1" colspan="1">1 390 539</td><td align="center" valign="top" rowspan="1" colspan="1">7494.33</td><td align="center" valign="top" rowspan="1" colspan="1">(7481.88&#x02013;7506.79)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Race/Ethnicity<sup><xref rid="TFN4" ref-type="table-fn">b</xref></sup></td><td align="right" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="right" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="right" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="right" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="right" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;White, NH</td><td align="right" valign="top" rowspan="1" colspan="1">11 342</td><td align="center" valign="top" rowspan="1" colspan="1">4.34</td><td align="center" valign="top" rowspan="1" colspan="1">(4.26&#x02013;4.42)</td><td align="right" valign="top" rowspan="1" colspan="1">65</td><td align="left" valign="top" rowspan="1" colspan="1">0.03</td><td align="center" valign="top" rowspan="1" colspan="1">(.02&#x02013;.03)</td><td align="right" valign="top" rowspan="1" colspan="1">868</td><td align="center" valign="top" rowspan="1" colspan="1">0.34</td><td align="center" valign="top" rowspan="1" colspan="1">(.32&#x02013;.37)</td><td align="right" valign="top" rowspan="1" colspan="1">10 409</td><td align="center" valign="top" rowspan="1" colspan="1">3.97</td><td align="center" valign="top" rowspan="1" colspan="1">(3.89&#x02013;4.04)</td><td align="right" valign="top" rowspan="1" colspan="1">1 960 321</td><td align="center" valign="top" rowspan="1" colspan="1">778.83</td><td align="center" valign="top" rowspan="1" colspan="1">(777.78&#x02013;779.87)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Black, NH</td><td align="right" valign="top" rowspan="1" colspan="1">3443</td><td align="center" valign="top" rowspan="1" colspan="1">8.93</td><td align="center" valign="top" rowspan="1" colspan="1">(8.81&#x02013;9.04)</td><td align="right" valign="top" rowspan="1" colspan="1">16</td><td align="left" valign="top" rowspan="1" colspan="1">0.04</td><td align="center" valign="top" rowspan="1" colspan="1">(.03&#x02013;.05)</td><td align="right" valign="top" rowspan="1" colspan="1">385</td><td align="center" valign="top" rowspan="1" colspan="1">1.02</td><td align="center" valign="top" rowspan="1" colspan="1">(.98&#x02013;1.06)</td><td align="right" valign="top" rowspan="1" colspan="1">3042</td><td align="center" valign="top" rowspan="1" colspan="1">7.87</td><td align="center" valign="top" rowspan="1" colspan="1">(7.76&#x02013;7.97)</td><td align="right" valign="top" rowspan="1" colspan="1">280 358</td><td align="center" valign="top" rowspan="1" colspan="1">917.89</td><td align="center" valign="top" rowspan="1" colspan="1">(916.76&#x02013;919.03)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Hispanic</td><td align="right" valign="top" rowspan="1" colspan="1">2503</td><td align="center" valign="top" rowspan="1" colspan="1">7.38</td><td align="center" valign="top" rowspan="1" colspan="1">(7.28&#x02013;7.48)</td><td align="right" valign="top" rowspan="1" colspan="1">12</td><td align="left" valign="top" rowspan="1" colspan="1">0.03</td><td align="center" valign="top" rowspan="1" colspan="1">(.03&#x02013;.04)</td><td align="right" valign="top" rowspan="1" colspan="1">143</td><td align="center" valign="top" rowspan="1" colspan="1">0.45</td><td align="center" valign="top" rowspan="1" colspan="1">(.42&#x02013;.47)</td><td align="right" valign="top" rowspan="1" colspan="1">2348</td><td align="center" valign="top" rowspan="1" colspan="1">6.9</td><td align="center" valign="top" rowspan="1" colspan="1">(6.80&#x02013;7.00)</td><td align="right" valign="top" rowspan="1" colspan="1">141 470</td><td align="center" valign="top" rowspan="1" colspan="1">541.91</td><td align="center" valign="top" rowspan="1" colspan="1">(541.04&#x02013;542.78)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Asian/Pacific Islander</td><td align="right" valign="top" rowspan="1" colspan="1">842</td><td align="center" valign="top" rowspan="1" colspan="1">6.11</td><td align="center" valign="top" rowspan="1" colspan="1">(6.02&#x02013;6.20)</td><td align="right" valign="top" rowspan="1" colspan="1">2</td><td align="left" valign="top" rowspan="1" colspan="1">0.02</td><td align="center" valign="top" rowspan="1" colspan="1">(.01 &#x02212;.02)</td><td align="right" valign="top" rowspan="1" colspan="1">425</td><td align="center" valign="top" rowspan="1" colspan="1">2.98</td><td align="center" valign="top" rowspan="1" colspan="1">(2.91&#x02013;3.04)</td><td align="right" valign="top" rowspan="1" colspan="1">415</td><td align="center" valign="top" rowspan="1" colspan="1">3.11</td><td align="center" valign="top" rowspan="1" colspan="1">(3.05&#x02013;3.18)</td><td align="right" valign="top" rowspan="1" colspan="1">50 707</td><td align="center" valign="top" rowspan="1" colspan="1">426.76</td><td align="center" valign="top" rowspan="1" colspan="1">(425.99&#x02013;427.53)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;American Indian/Alaska Native</td><td align="right" valign="top" rowspan="1" colspan="1">270</td><td align="center" valign="top" rowspan="1" colspan="1">10.85</td><td align="center" valign="top" rowspan="1" colspan="1">(10.73&#x02013;10.97)</td><td align="right" valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1">0.05</td><td align="center" valign="top" rowspan="1" colspan="1">(.04&#x02013;.06)</td><td align="right" valign="top" rowspan="1" colspan="1">17</td><td align="center" valign="top" rowspan="1" colspan="1">0.73</td><td align="center" valign="top" rowspan="1" colspan="1">(.70&#x02013;.77)</td><td align="right" valign="top" rowspan="1" colspan="1">252</td><td align="center" valign="top" rowspan="1" colspan="1">10.07</td><td align="center" valign="top" rowspan="1" colspan="1">(9.95&#x02013;10.19)</td><td align="right" valign="top" rowspan="1" colspan="1">15 314</td><td align="center" valign="top" rowspan="1" colspan="1">835.62</td><td align="center" valign="top" rowspan="1" colspan="1">(834.54&#x02013;836.70)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Sex</td><td align="right" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="right" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="right" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="right" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="right" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Male</td><td align="right" valign="top" rowspan="1" colspan="1">13 132</td><td align="center" valign="top" rowspan="1" colspan="1">7.65</td><td align="center" valign="top" rowspan="1" colspan="1">(7.55&#x02013;7.76)</td><td align="right" valign="top" rowspan="1" colspan="1">74</td><td align="left" valign="top" rowspan="1" colspan="1">0.05</td><td align="center" valign="top" rowspan="1" colspan="1">(.04&#x02013;.06)</td><td align="right" valign="top" rowspan="1" colspan="1">1359</td><td align="center" valign="top" rowspan="1" colspan="1">0.83</td><td align="center" valign="top" rowspan="1" colspan="1">(.80&#x02013;.87)</td><td align="right" valign="top" rowspan="1" colspan="1">11 699</td><td align="center" valign="top" rowspan="1" colspan="1">6.77</td><td align="center" valign="top" rowspan="1" colspan="1">(6.67&#x02013;6.87)</td><td align="right" valign="top" rowspan="1" colspan="1">1 222 070</td><td align="center" valign="top" rowspan="1" colspan="1">875.24</td><td align="center" valign="top" rowspan="1" colspan="1">(874.13&#x02013;876.34)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">&#x02003;Female</td><td align="right" valign="top" rowspan="1" colspan="1">5341</td><td align="center" valign="top" rowspan="1" colspan="1">2.92</td><td align="center" valign="top" rowspan="1" colspan="1">(2.85&#x02013;2.98)</td><td align="right" valign="top" rowspan="1" colspan="1">22</td><td align="left" valign="top" rowspan="1" colspan="1">0.01</td><td align="center" valign="top" rowspan="1" colspan="1">(.01 &#x02212;.02)</td><td align="right" valign="top" rowspan="1" colspan="1">485</td><td align="center" valign="top" rowspan="1" colspan="1">0.27</td><td align="center" valign="top" rowspan="1" colspan="1">(.26&#x02013;.29)</td><td align="right" valign="top" rowspan="1" colspan="1">4834</td><td align="center" valign="top" rowspan="1" colspan="1">2.63</td><td align="center" valign="top" rowspan="1" colspan="1">(2.57&#x02013;2.69)</td><td align="right" valign="top" rowspan="1" colspan="1">1 231 999</td><td align="center" valign="top" rowspan="1" colspan="1">671.73</td><td align="center" valign="top" rowspan="1" colspan="1">(670.76&#x02013;672.70)</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p id="P38">Source: Centers for Disease Control and Prevention. National Center for Health Statistics. National Vital Statistics System.</p></fn><fn id="TFN2"><p id="P39">Mortality rates are presented as per 100 000 population. Deaths listing &#x0003e;1 type of hepatitis infection were classified by using the following mutually exclusive hierarchy: hepatitis A &#x0003e; hepatitis B &#x0003e; hepatitis C. Abbreviations: CI, confidence interval; NH, non-Hispanic.</p></fn><fn id="TFN3"><label>a</label><p id="P40">Two deaths for hepatitis C were not represented under the age group category due to missing data.</p></fn><fn id="TFN4"><label>b</label><p id="P41">Six deaths for hepatitis B, 67 deaths for hepatitis C, and 5899 deaths for non&#x02013;hepatitis A, B, or C were not represented under the race/ethnicity category due to missing data.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="T2"><label>Table 2.</label><caption><p id="P42">Most Frequently Listed Categories of Causes of Death and Median Age at Death Among Decedents With and Without Hepatitis B in the United States, 2010</p></caption><table frame="hsides" rules="none"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" valign="bottom" rowspan="1" colspan="1">Ranking</th><th align="center" valign="bottom" rowspan="1" colspan="1">Category</th><th align="left" valign="bottom" rowspan="1" colspan="1">No.</th><th align="center" valign="bottom" rowspan="1" colspan="1">%<sup><xref rid="TFN7" ref-type="table-fn">a</xref></sup></th><th align="center" valign="bottom" rowspan="1" colspan="1">Median Age, y</th></tr></thead><tbody><tr><td colspan="5" align="left" valign="top" rowspan="1">Deaths with hepatitis B</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 151: Fibrosis, cirrhosis, and other liver diseases</td><td align="right" valign="top" rowspan="1" colspan="1">850</td><td align="center" valign="top" rowspan="1" colspan="1">45.3</td><td align="center" valign="top" rowspan="1" colspan="1">58</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 6: Hepatitis (excluding hepatitis B)</td><td align="right" valign="top" rowspan="1" colspan="1">573</td><td align="center" valign="top" rowspan="1" colspan="1">30.6</td><td align="center" valign="top" rowspan="1" colspan="1">56</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">3</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 16: Cancer of liver and intrahepatic bile duct</td><td align="right" valign="top" rowspan="1" colspan="1">427</td><td align="center" valign="top" rowspan="1" colspan="1">22.8</td><td align="center" valign="top" rowspan="1" colspan="1">59</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">4</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 107: Cardiac arrest and ventricular fibrillation</td><td align="right" valign="top" rowspan="1" colspan="1">232</td><td align="center" valign="top" rowspan="1" colspan="1">12.4</td><td align="center" valign="top" rowspan="1" colspan="1">58</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">5</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 67: Substance-related mental disorders</td><td align="right" valign="top" rowspan="1" colspan="1">218</td><td align="center" valign="top" rowspan="1" colspan="1">11.6</td><td align="center" valign="top" rowspan="1" colspan="1">57</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">6</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 150: Liver disease, alcohol-related</td><td align="right" valign="top" rowspan="1" colspan="1">211</td><td align="center" valign="top" rowspan="1" colspan="1">11.3</td><td align="center" valign="top" rowspan="1" colspan="1">55</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">7</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 157: Acute and unspecified renal failure</td><td align="right" valign="top" rowspan="1" colspan="1">198</td><td align="center" valign="top" rowspan="1" colspan="1">10.6</td><td align="center" valign="top" rowspan="1" colspan="1">57</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">8</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 49: Diabetes mellitus without complication</td><td align="right" valign="top" rowspan="1" colspan="1">190</td><td align="center" valign="top" rowspan="1" colspan="1">10.1</td><td align="center" valign="top" rowspan="1" colspan="1">59</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">9</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 98: Essential hypertension</td><td align="right" valign="top" rowspan="1" colspan="1">169</td><td align="center" valign="top" rowspan="1" colspan="1">9.0</td><td align="center" valign="top" rowspan="1" colspan="1">61</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">10</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 131: Respiratory failure, insufficiency, arrest (adult)</td><td align="right" valign="top" rowspan="1" colspan="1">168</td><td align="center" valign="top" rowspan="1" colspan="1">9.0</td><td align="center" valign="top" rowspan="1" colspan="1">58</td></tr><tr><td colspan="5" align="left" valign="top" rowspan="1">Deaths without hepatitis B</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 101: Coronary atherosclerosis and other heart disease</td><td align="right" valign="top" rowspan="1" colspan="1">372 568</td><td align="center" valign="top" rowspan="1" colspan="1">15.1</td><td align="center" valign="top" rowspan="1" colspan="1">82</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 107: Cardiac arrest and ventricular fibrillation</td><td align="right" valign="top" rowspan="1" colspan="1">339 188</td><td align="center" valign="top" rowspan="1" colspan="1">13.7</td><td align="center" valign="top" rowspan="1" colspan="1">79</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">3</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 68: Senility and organic mental disorders</td><td align="right" valign="top" rowspan="1" colspan="1">332 865</td><td align="center" valign="top" rowspan="1" colspan="1">13.5</td><td align="center" valign="top" rowspan="1" colspan="1">87</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">4</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 98: Essential hypertension</td><td align="right" valign="top" rowspan="1" colspan="1">297 406</td><td align="center" valign="top" rowspan="1" colspan="1">12.0</td><td align="center" valign="top" rowspan="1" colspan="1">82</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">5</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 108: Congestive heart failure, nonhypertensive</td><td align="right" valign="top" rowspan="1" colspan="1">279 188</td><td align="center" valign="top" rowspan="1" colspan="1">11.3</td><td align="center" valign="top" rowspan="1" colspan="1">85</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">6</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 131: Respiratory failure, insufficiency, arrest (adult)</td><td align="right" valign="top" rowspan="1" colspan="1">269 112</td><td align="center" valign="top" rowspan="1" colspan="1">10.9</td><td align="center" valign="top" rowspan="1" colspan="1">78</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">7</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 127: Chronic obstructive pulmonary disease and bronchiecstasis</td><td align="right" valign="top" rowspan="1" colspan="1">262 622</td><td align="center" valign="top" rowspan="1" colspan="1">10.6</td><td align="center" valign="top" rowspan="1" colspan="1">78</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">8</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 67: Substance-related mental disorders</td><td align="right" valign="top" rowspan="1" colspan="1">251 286</td><td align="center" valign="top" rowspan="1" colspan="1">10.2</td><td align="center" valign="top" rowspan="1" colspan="1">71</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">9</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 49: Diabetes mellitus without complication</td><td align="right" valign="top" rowspan="1" colspan="1">205 112</td><td align="center" valign="top" rowspan="1" colspan="1">8.3</td><td align="center" valign="top" rowspan="1" colspan="1">76</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">10</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 109: Acute cerebrovascular disease</td><td align="right" valign="top" rowspan="1" colspan="1">177 231</td><td align="center" valign="top" rowspan="1" colspan="1">7.2</td><td align="center" valign="top" rowspan="1" colspan="1">82</td></tr></tbody></table><table-wrap-foot><fn id="TFN5"><p id="P43">Source: Centers for Disease Control and Prevention. National Center for Health Statistics. National Vital Statistics System.</p></fn><fn id="TFN6"><p id="P44">Abbreviation: CCS, Clinical Classifications Software.</p></fn><fn id="TFN7"><label>a</label><p id="P45">Cumulative percentages will not equal 100% because a death listing multiple causes of death can be placed into &#x0003e;1 category and only the 10 most frequent categories among deaths with hepatitis B are listed. The denominator equals 1875 for deaths with hepatitis B and 2 470 667 for deaths without hepatitis B.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="T3"><label>Table 3.</label><caption><p id="P46">Most Frequently Listed Categories of Causes of Death and Median Age at Death Among Decedents With and Without Hepatitis C in the United States, 2010</p></caption><table frame="hsides" rules="none"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" valign="bottom" rowspan="1" colspan="1">Ranking</th><th align="center" valign="bottom" rowspan="1" colspan="1">CCS Category</th><th align="left" valign="bottom" rowspan="1" colspan="1">No.</th><th align="center" valign="bottom" rowspan="1" colspan="1">%<sup><xref rid="TFN10" ref-type="table-fn">a</xref></sup></th><th align="center" valign="bottom" rowspan="1" colspan="1">Median Age</th></tr></thead><tbody><tr><td colspan="5" align="left" valign="top" rowspan="1">Deaths with hepatitis C</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 151: Fibrosis, cirrhosis, and other liver diseases</td><td align="right" valign="top" rowspan="1" colspan="1">8278</td><td align="center" valign="top" rowspan="1" colspan="1">48.4</td><td align="center" valign="top" rowspan="1" colspan="1">57</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 16: Cancer of liver and intrahepatic bile duct</td><td align="right" valign="top" rowspan="1" colspan="1">2900</td><td align="center" valign="top" rowspan="1" colspan="1">17.0</td><td align="center" valign="top" rowspan="1" colspan="1">59</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">3</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 150: Liver disease, alcohol-related</td><td align="right" valign="top" rowspan="1" colspan="1">2831</td><td align="center" valign="top" rowspan="1" colspan="1">16.5</td><td align="center" valign="top" rowspan="1" colspan="1">55</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">4</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 67: Substance-related mental disorders</td><td align="right" valign="top" rowspan="1" colspan="1">2390</td><td align="center" valign="top" rowspan="1" colspan="1">14.0</td><td align="center" valign="top" rowspan="1" colspan="1">56</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">5</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 107: Cardiac arrest and ventricular fibrillation</td><td align="right" valign="top" rowspan="1" colspan="1">1817</td><td align="center" valign="top" rowspan="1" colspan="1">10.6</td><td align="center" valign="top" rowspan="1" colspan="1">57</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">6</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 49: Diabetes mellitus without complication</td><td align="right" valign="top" rowspan="1" colspan="1">1741</td><td align="center" valign="top" rowspan="1" colspan="1">10.2</td><td align="center" valign="top" rowspan="1" colspan="1">58</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">7</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 98: Essential hypertension</td><td align="right" valign="top" rowspan="1" colspan="1">1683</td><td align="center" valign="top" rowspan="1" colspan="1">9.8</td><td align="center" valign="top" rowspan="1" colspan="1">59</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">8</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 2: Septicemia (except in labor)</td><td align="right" valign="top" rowspan="1" colspan="1">1658</td><td align="center" valign="top" rowspan="1" colspan="1">9.7</td><td align="center" valign="top" rowspan="1" colspan="1">56</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">9</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 131: Respiratory failure, insufficiency, arrest (adult)</td><td align="right" valign="top" rowspan="1" colspan="1">1565</td><td align="center" valign="top" rowspan="1" colspan="1">9.2</td><td align="center" valign="top" rowspan="1" colspan="1">57</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">10</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 157: Acute and unspecified renal failure</td><td align="right" valign="top" rowspan="1" colspan="1">1523</td><td align="center" valign="top" rowspan="1" colspan="1">8.9</td><td align="center" valign="top" rowspan="1" colspan="1">57</td></tr><tr><td colspan="5" align="left" valign="top" rowspan="1">Deaths without hepatitis C</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 101: Coronary atherosclerosis and other heart disease</td><td align="right" valign="top" rowspan="1" colspan="1">371 852</td><td align="center" valign="top" rowspan="1" colspan="1">15.1</td><td align="center" valign="top" rowspan="1" colspan="1">82</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 107: Cardiac arrest and ventricular fibrillation</td><td align="right" valign="top" rowspan="1" colspan="1">337 603</td><td align="center" valign="top" rowspan="1" colspan="1">13.8</td><td align="center" valign="top" rowspan="1" colspan="1">79</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">3</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 68: Senility and organic mental disorders</td><td align="right" valign="top" rowspan="1" colspan="1">332 694</td><td align="center" valign="top" rowspan="1" colspan="1">13.6</td><td align="center" valign="top" rowspan="1" colspan="1">87</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">4</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 98: Essential hypertension</td><td align="right" valign="top" rowspan="1" colspan="1">295 892</td><td align="center" valign="top" rowspan="1" colspan="1">12.1</td><td align="center" valign="top" rowspan="1" colspan="1">82</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">5</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 108: Congestive heart failure, nonhypertensive</td><td align="right" valign="top" rowspan="1" colspan="1">278 617</td><td align="center" valign="top" rowspan="1" colspan="1">11.4</td><td align="center" valign="top" rowspan="1" colspan="1">85</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">6</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 131: Respiratory failure, insufficiency, arrest (adult)</td><td align="right" valign="top" rowspan="1" colspan="1">267 715</td><td align="center" valign="top" rowspan="1" colspan="1">10.9</td><td align="center" valign="top" rowspan="1" colspan="1">78</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">7</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 127: Chronic obstructive pulmonary disease and bronchiecstasis</td><td align="right" valign="top" rowspan="1" colspan="1">261 400</td><td align="center" valign="top" rowspan="1" colspan="1">10.7</td><td align="center" valign="top" rowspan="1" colspan="1">78</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">8</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 67: Substance-related mental disorders</td><td align="right" valign="top" rowspan="1" colspan="1">249 114</td><td align="center" valign="top" rowspan="1" colspan="1">10.2</td><td align="center" valign="top" rowspan="1" colspan="1">71</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">9</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 49: Diabetes mellitus without complication</td><td align="right" valign="top" rowspan="1" colspan="1">203 561</td><td align="center" valign="top" rowspan="1" colspan="1">8.3</td><td align="center" valign="top" rowspan="1" colspan="1">76</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">10</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 109: Acute cerebrovascular disease</td><td align="right" valign="top" rowspan="1" colspan="1">176 844</td><td align="center" valign="top" rowspan="1" colspan="1">7.2</td><td align="center" valign="top" rowspan="1" colspan="1">82</td></tr></tbody></table><table-wrap-foot><fn id="TFN8"><p id="P47">Source: Centers for Disease Control and Prevention. National Center for Health Statistics. National Vital Statistics System.</p></fn><fn id="TFN9"><p id="P48">Abbreviation: CCS, Clinical Classifications Software.</p></fn><fn id="TFN10"><label>a</label><p id="P49">Cumulative percentages will not equal 100% because a death listing multiple causes of death can be placed into &#x0003e;1 category and only the 10 most frequent categories among deaths with hepatitis C are listed. The denominator equals 17 113 for deaths with hepatitis C and 2 455 429 for deaths without hepatitis C.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="T4" orientation="landscape"><label>Table 4.</label><caption><p id="P50">Most Frequently Listed Categories of Causes of Death Among Decedents Aged 45&#x02013;64 Years With and Without Hepatitis B in the United States, 2010</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th rowspan="2" align="left" valign="bottom" colspan="1">Ranking by Frequency</th><th rowspan="2" align="center" valign="bottom" colspan="1">Category</th><th rowspan="2" align="left" valign="bottom" colspan="1">With/Without CCS Category</th><th colspan="2" align="center" valign="bottom" style="border-bottom: solid 1px" rowspan="1">Hepatitis B<sup><xref rid="TFN14" ref-type="table-fn">a</xref></sup></th><th rowspan="2" align="center" valign="bottom" colspan="1">RR (95% CI)</th></tr><tr><th align="center" valign="bottom" rowspan="1" colspan="1">With n = 662</th><th align="center" valign="bottom" rowspan="1" colspan="1">Without n = 494 662</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 151: Fibrosis, cirrhosis, and other liver diseases</td><td align="left" valign="top" rowspan="1" colspan="1">With</td><td align="center" valign="top" rowspan="1" colspan="1">299 (45.2%)</td><td align="center" valign="top" rowspan="1" colspan="1">33 208 (6.7%)</td><td align="center" valign="top" rowspan="1" colspan="1">6.73 (6.18, 7.32)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Without</td><td align="center" valign="top" rowspan="1" colspan="1">363 (54.8%)</td><td align="center" valign="top" rowspan="1" colspan="1">461 454 (93.3%)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 16: Cancer of liver and intrahepatic bile duct</td><td align="left" valign="top" rowspan="1" colspan="1">With</td><td align="center" valign="top" rowspan="1" colspan="1">170 (25.7%)</td><td align="center" valign="top" rowspan="1" colspan="1">8855 (1.8%)</td><td align="center" valign="top" rowspan="1" colspan="1">14.35 (12.58, 16.36)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Without</td><td align="center" valign="top" rowspan="1" colspan="1">492 (74.3%)</td><td align="center" valign="top" rowspan="1" colspan="1">485 807 (98.2%)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">3</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 107: Cardiac arrest and ventricular fibrillation</td><td align="left" valign="top" rowspan="1" colspan="1">With</td><td align="center" valign="top" rowspan="1" colspan="1">87 (13.1%)</td><td align="center" valign="top" rowspan="1" colspan="1">64 331 (13.0%)</td><td align="center" valign="top" rowspan="1" colspan="1">1.01 (.83, 1.23)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Without</td><td align="center" valign="top" rowspan="1" colspan="1">575 (86.9%)</td><td align="center" valign="top" rowspan="1" colspan="1">430 331 (87.0%)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">4</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 157: Acute and unspecified renal failure</td><td align="left" valign="top" rowspan="1" colspan="1">With</td><td align="center" valign="top" rowspan="1" colspan="1">79 (11.9%)</td><td align="center" valign="top" rowspan="1" colspan="1">22 518 (4.6%)</td><td align="center" valign="top" rowspan="1" colspan="1">2.62 (2.13, 3.23)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Without</td><td align="center" valign="top" rowspan="1" colspan="1">583 (88.1%)</td><td align="center" valign="top" rowspan="1" colspan="1">472 144 (95.4%)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">5</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 150: Liver disease, alcohol-related</td><td align="left" valign="top" rowspan="1" colspan="1">With</td><td align="center" valign="top" rowspan="1" colspan="1">71 (10.7%)</td><td align="center" valign="top" rowspan="1" colspan="1">14 252 (2.9%)</td><td align="center" valign="top" rowspan="1" colspan="1">3.72 (2.99, 4.64)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Without</td><td align="center" valign="top" rowspan="1" colspan="1">591 (89.3%)</td><td align="center" valign="top" rowspan="1" colspan="1">480 410 (97.1%)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">6</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 49: Diabetes mellitus without complication</td><td align="left" valign="top" rowspan="1" colspan="1">With</td><td align="center" valign="top" rowspan="1" colspan="1">66 (10.0%)</td><td align="center" valign="top" rowspan="1" colspan="1">45 219 (9.1%)</td><td align="center" valign="top" rowspan="1" colspan="1">1.09 (.87, 1.37)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Without</td><td align="center" valign="top" rowspan="1" colspan="1">596 (90.0%)</td><td align="center" valign="top" rowspan="1" colspan="1">449 443 (90.9%)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">7</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 67: Substance-related mental disorders</td><td align="left" valign="top" rowspan="1" colspan="1">With</td><td align="center" valign="top" rowspan="1" colspan="1">64 (9.7%)</td><td align="center" valign="top" rowspan="1" colspan="1">71 892 (14.5%)</td><td align="center" valign="top" rowspan="1" colspan="1">0.67 (.53, .84)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Without</td><td align="center" valign="top" rowspan="1" colspan="1">598 (90.3%)</td><td align="center" valign="top" rowspan="1" colspan="1">422 770 (85.5%)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">8</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 131: Respiratory failure, insufficiency, arrest (adult)</td><td align="left" valign="top" rowspan="1" colspan="1">With</td><td align="center" valign="top" rowspan="1" colspan="1">61 (9.2%)</td><td align="center" valign="top" rowspan="1" colspan="1">49 713 (10.0%)</td><td align="center" valign="top" rowspan="1" colspan="1">0.92 (.72, 1.16)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Without</td><td align="center" valign="top" rowspan="1" colspan="1">601 (90.8%)</td><td align="center" valign="top" rowspan="1" colspan="1">444 949 (90.0%)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">9</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 5: HIV infection</td><td align="left" valign="top" rowspan="1" colspan="1">With</td><td align="center" valign="top" rowspan="1" colspan="1">57 (8.6%)</td><td align="center" valign="top" rowspan="1" colspan="1">6082 (1.2%)</td><td align="center" valign="top" rowspan="1" colspan="1">7.00 (5.46, 8.99)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Without</td><td align="center" valign="top" rowspan="1" colspan="1">605 (91.4%)</td><td align="center" valign="top" rowspan="1" colspan="1">488 580 (98.8%)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">10</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 2: Septicemia (except in labor)</td><td align="left" valign="top" rowspan="1" colspan="1">With</td><td align="center" valign="top" rowspan="1" colspan="1">56 (8.5%)</td><td align="center" valign="top" rowspan="1" colspan="1">34 659 (7.0%)</td><td align="center" valign="top" rowspan="1" colspan="1">1.21 (.94, 1.55)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Without</td><td align="center" valign="top" rowspan="1" colspan="1">606 (91.5%)</td><td align="center" valign="top" rowspan="1" colspan="1">460 003 (93.0%)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">11</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 259: Residual codes, unclassified</td><td align="left" valign="top" rowspan="1" colspan="1">With</td><td align="center" valign="top" rowspan="1" colspan="1">55 (8.3%)</td><td align="center" valign="top" rowspan="1" colspan="1">18 325 (3.7%)</td><td align="center" valign="top" rowspan="1" colspan="1">2.24 (1.74, 2.89)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Without</td><td align="center" valign="top" rowspan="1" colspan="1">607 (91.7%)</td><td align="center" valign="top" rowspan="1" colspan="1">476 337 (96.3%)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">12</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 98: Essential hypertension</td><td align="left" valign="top" rowspan="1" colspan="1">With</td><td align="center" valign="top" rowspan="1" colspan="1">50 (7.6%)</td><td align="center" valign="top" rowspan="1" colspan="1">43 621 (8.8%)</td><td align="center" valign="top" rowspan="1" colspan="1">0.86 (.66, 1.12)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Without</td><td align="center" valign="top" rowspan="1" colspan="1">612 (92.4%)</td><td align="center" valign="top" rowspan="1" colspan="1">451 041 (91.2%)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">13</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 127: Chronic obstructive pulmonary disease and bronchiectasis</td><td align="left" valign="top" rowspan="1" colspan="1">With</td><td align="center" valign="top" rowspan="1" colspan="1">44 (6.6%)</td><td align="center" valign="top" rowspan="1" colspan="1">39 406 (8.0%)</td><td align="center" valign="top" rowspan="1" colspan="1">0.83 (.63, 1.11)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Without</td><td align="center" valign="top" rowspan="1" colspan="1">618 (93.4%)</td><td align="center" valign="top" rowspan="1" colspan="1">455 256 (92.0%)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">14</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 153: Gastrointestinal hemorrhage</td><td align="left" valign="top" rowspan="1" colspan="1">With</td><td align="center" valign="top" rowspan="1" colspan="1">35 (5.3%)</td><td align="center" valign="top" rowspan="1" colspan="1">8334 (1.7%)</td><td align="center" valign="top" rowspan="1" colspan="1">3.14 (2.27, 4.34)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Without</td><td align="center" valign="top" rowspan="1" colspan="1">627 (94.7%)</td><td align="center" valign="top" rowspan="1" colspan="1">486 328 (98.3%)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">15</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 101: Coronary atherosclerosis and other heart disease</td><td align="left" valign="top" rowspan="1" colspan="1">With</td><td align="center" valign="top" rowspan="1" colspan="1">33 (5.0%)</td><td align="center" valign="top" rowspan="1" colspan="1">51 532 (10.4%)</td><td align="center" valign="top" rowspan="1" colspan="1">0.48 (.34, .67)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Without</td><td align="center" valign="top" rowspan="1" colspan="1">629 (95.0%)</td><td align="center" valign="top" rowspan="1" colspan="1">443 130 (89.6%)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="TFN11"><p id="P51">Source: Centers for Disease Control and Prevention. National Center for Health Statistics. National Vital Statistics System.</p></fn><fn id="TFN12"><p id="P52">Data are presented as No. (%) unless otherwise specified.</p></fn><fn id="TFN13"><p id="P53">Abbreviations: CCS, Clinical Classifications Software; CI, confidence interval; HIV, human immunodeficiency virus; RR, relative risk.</p></fn><fn id="TFN14"><label>a</label><p id="P54">Identified in the absence of hepatitis C.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="T5" orientation="landscape"><label>Table 5.</label><caption><p id="P55">Most Frequently Listed Categories of Causes of Death Among Decedents Aged 45&#x02013;64 Years With and Without Hepatitis C in the United States, 2010</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th rowspan="2" align="left" valign="bottom" colspan="1">Ranking by Frequency</th><th rowspan="2" align="center" valign="bottom" colspan="1">Category</th><th rowspan="2" align="center" valign="bottom" colspan="1">With/Without CCS Category</th><th colspan="2" align="center" valign="bottom" style="border-bottom: solid 1px" rowspan="1">Hepatitis C<sup><xref rid="TFN18" ref-type="table-fn">a</xref></sup></th><th rowspan="2" align="center" valign="bottom" colspan="1">RR (95% CI)</th></tr><tr><th align="center" valign="bottom" rowspan="1" colspan="1">With n = 12 533</th><th align="center" valign="bottom" rowspan="1" colspan="1">Without n = 482 791</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">1</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 151: Fibrosis, cirrhosis, and other liver diseases</td><td align="left" valign="top" rowspan="1" colspan="1">With</td><td align="center" valign="top" rowspan="1" colspan="1">6009 (47.9%)</td><td align="center" valign="top" rowspan="1" colspan="1">27498 (5.7%)</td><td align="center" valign="top" rowspan="1" colspan="1">8.42 (8.24, 8.60)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Without</td><td align="center" valign="top" rowspan="1" colspan="1">6524 (52.1%)</td><td align="center" valign="top" rowspan="1" colspan="1">455 293 (94.3%)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">2</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 150: Liver disease, alcohol-related</td><td align="left" valign="top" rowspan="1" colspan="1">With</td><td align="center" valign="top" rowspan="1" colspan="1">2375 (18.9%)</td><td align="center" valign="top" rowspan="1" colspan="1">11 948 (2.5%)</td><td align="center" valign="top" rowspan="1" colspan="1">7.66 (7.35, 7.97)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Without</td><td align="center" valign="top" rowspan="1" colspan="1">10 158 (81.1%)</td><td align="center" valign="top" rowspan="1" colspan="1">470 843 (97.5%)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">3</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 16: Cancer of liver and intrahepatic bile duct</td><td align="left" valign="top" rowspan="1" colspan="1">With</td><td align="center" valign="top" rowspan="1" colspan="1">2138 (17.1%)</td><td align="center" valign="top" rowspan="1" colspan="1">6887 (1.4%)</td><td align="center" valign="top" rowspan="1" colspan="1">11.96 (11.43, 12.51)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Without</td><td align="center" valign="top" rowspan="1" colspan="1">10 395 (82.9%)</td><td align="center" valign="top" rowspan="1" colspan="1">475 904 (98.6%)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">4</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 67: Substance-related mental disorders</td><td align="left" valign="top" rowspan="1" colspan="1">With</td><td align="center" valign="top" rowspan="1" colspan="1">1881 (15.0%)</td><td align="center" valign="top" rowspan="1" colspan="1">70 075 (14.5%)</td><td align="center" valign="top" rowspan="1" colspan="1">1.03 (.99, 1.08)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Without</td><td align="center" valign="top" rowspan="1" colspan="1">10 652 (85.0%)</td><td align="center" valign="top" rowspan="1" colspan="1">412 716 (85.5%)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">5</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 2: Septicemia (except in labor)</td><td align="left" valign="top" rowspan="1" colspan="1">With</td><td align="center" valign="top" rowspan="1" colspan="1">1266 (10.1%)</td><td align="center" valign="top" rowspan="1" colspan="1">33 449 (6.9%)</td><td align="center" valign="top" rowspan="1" colspan="1">1.46 (1.38, 1.54)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Without</td><td align="center" valign="top" rowspan="1" colspan="1">11 267 (89.9%)</td><td align="center" valign="top" rowspan="1" colspan="1">449 342 (93.1%)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">6</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 107: Cardiac arrest and ventricular fibrillation</td><td align="left" valign="top" rowspan="1" colspan="1">With</td><td align="center" valign="top" rowspan="1" colspan="1">1251 (10.0%)</td><td align="center" valign="top" rowspan="1" colspan="1">63 167 (13.1%)</td><td align="center" valign="top" rowspan="1" colspan="1">0.76 (.72, .80)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Without</td><td align="center" valign="top" rowspan="1" colspan="1">11 282 (90.0%)</td><td align="center" valign="top" rowspan="1" colspan="1">419 624 (86.9%)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">7</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 49: Diabetes mellitus without complication</td><td align="left" valign="top" rowspan="1" colspan="1">With</td><td align="center" valign="top" rowspan="1" colspan="1">1206 (9.6%)</td><td align="center" valign="top" rowspan="1" colspan="1">44 079 (9.1%)</td><td align="center" valign="top" rowspan="1" colspan="1">1.05 (1.00, 1.11)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Without</td><td align="center" valign="top" rowspan="1" colspan="1">11 327 (90.4%)</td><td align="center" valign="top" rowspan="1" colspan="1">438 712 (90.9%)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">8</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 131: Respiratory failure, insufficiency, arrest (adult)</td><td align="left" valign="top" rowspan="1" colspan="1">With</td><td align="center" valign="top" rowspan="1" colspan="1">1146 (9.1%)</td><td align="center" valign="top" rowspan="1" colspan="1">48 628 (10.1%)</td><td align="center" valign="top" rowspan="1" colspan="1">0.91 (.86, .96)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Without</td><td align="center" valign="top" rowspan="1" colspan="1">11 387 (90.9%)</td><td align="center" valign="top" rowspan="1" colspan="1">434 163 (89.9%)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">9</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 98: Essential hypertension</td><td align="left" valign="top" rowspan="1" colspan="1">With</td><td align="center" valign="top" rowspan="1" colspan="1">1140 (9.1%)</td><td align="center" valign="top" rowspan="1" colspan="1">42 531 (8.9%)</td><td align="center" valign="top" rowspan="1" colspan="1">1.03 (.98, 1.09)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Without</td><td align="center" valign="top" rowspan="1" colspan="1">11 393 (90.9%)</td><td align="center" valign="top" rowspan="1" colspan="1">440 260 (91.2%)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">10</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 157: Acute and unspecified renal failure</td><td align="left" valign="top" rowspan="1" colspan="1">With</td><td align="center" valign="top" rowspan="1" colspan="1">1093 (8.7%)</td><td align="center" valign="top" rowspan="1" colspan="1">21 504 (4.5%)</td><td align="center" valign="top" rowspan="1" colspan="1">1.96 (1.85, 2.08)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Without</td><td align="center" valign="top" rowspan="1" colspan="1">11 440 (91.3%)</td><td align="center" valign="top" rowspan="1" colspan="1">461 287 (95.5%)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">11</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 127: Chronic obstructive pulmonary disease and bronchiectasis</td><td align="left" valign="top" rowspan="1" colspan="1">With</td><td align="center" valign="top" rowspan="1" colspan="1">967 (7.7%)</td><td align="center" valign="top" rowspan="1" colspan="1">38 483 (8.0%)</td><td align="center" valign="top" rowspan="1" colspan="1">0.97 (.91, 1.03)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Without</td><td align="center" valign="top" rowspan="1" colspan="1">11 566 (92.3%)</td><td align="center" valign="top" rowspan="1" colspan="1">444 308 (92.0%)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">12</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 153: Gastrointestinal hemorrhage</td><td align="left" valign="top" rowspan="1" colspan="1">With</td><td align="center" valign="top" rowspan="1" colspan="1">863 (6.9%)</td><td align="center" valign="top" rowspan="1" colspan="1">7506 (1.6%)</td><td align="center" valign="top" rowspan="1" colspan="1">4.43 (4.14, 4.74)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Without</td><td align="center" valign="top" rowspan="1" colspan="1">11 670 (93.1%)</td><td align="center" valign="top" rowspan="1" colspan="1">475 285 (98.4%)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">13</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 259: Residual codes, unclassified</td><td align="left" valign="top" rowspan="1" colspan="1">With</td><td align="center" valign="top" rowspan="1" colspan="1">856 (6.8%)</td><td align="center" valign="top" rowspan="1" colspan="1">17 524 (3.6%)</td><td align="center" valign="top" rowspan="1" colspan="1">1.88 (1.76, 2.01)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Without</td><td align="center" valign="top" rowspan="1" colspan="1">11 677 (93.2%)</td><td align="center" valign="top" rowspan="1" colspan="1">465 267 (96.4%)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">14</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 5: HIV infection</td><td align="left" valign="top" rowspan="1" colspan="1">With</td><td align="center" valign="top" rowspan="1" colspan="1">641 (5.1%)</td><td align="center" valign="top" rowspan="1" colspan="1">5498 (1.1%)</td><td align="center" valign="top" rowspan="1" colspan="1">4.49 (4.15, 4.86)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Without</td><td align="center" valign="top" rowspan="1" colspan="1">11 892 (94.9%)</td><td align="center" valign="top" rowspan="1" colspan="1">477 293 (98.9%)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">15</td><td align="left" valign="top" rowspan="1" colspan="1">CCS 260: E codes: all (external causes of injury and poisoning)</td><td align="left" valign="top" rowspan="1" colspan="1">With</td><td align="center" valign="top" rowspan="1" colspan="1">579 (4.6%)</td><td align="center" valign="top" rowspan="1" colspan="1">40 895 (8.5%)</td><td align="center" valign="top" rowspan="1" colspan="1">0.55 (.50, .59)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">Without</td><td align="center" valign="top" rowspan="1" colspan="1">11 954 (95.4%)</td><td align="center" valign="top" rowspan="1" colspan="1">441 896 (91.5%)</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="TFN15"><p id="P56">Source: Centers for Disease Control and Prevention. National Center for Health Statistics. National Vital Statistics System.</p></fn><fn id="TFN16"><p id="P57">Data are presented as No. (%) unless otherwise specified.</p></fn><fn id="TFN17"><p id="P58">Abbreviations: CCS, Clinical Classifications Software; CI, confidence interval; HIV, human immunodeficiency virus; RR, relative risk.</p></fn><fn id="TFN18"><label>a</label><p id="P59">Identified in the absence of hepatitis B.</p></fn></table-wrap-foot></table-wrap></floats-group></article>